fongms的个人主页 - 老虎社区

fongms

fongms

暂无个人介绍

IP属地：未知

188关注

8粉丝

0主题

0勋章

2021-10-07

Like please

抱歉，原内容已删除

2021-12-01

Pfizer

Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna或辉瑞股票：随着奥密克戎蔓延，该买哪一只？</blockquote>

2021-11-26

Its good

Fear, Not Calculated Trading, Is Behind Today’s Covid Market Crash<blockquote>今天新冠市场崩盘的背后是恐惧，而不是经过计算的交易</blockquote>

2021-11-10

Cool

抱歉，原内容已删除

2021-10-08

Its a good start

Vaxart gained 7% in premarket trading<blockquote>Vaxart在盘前交易中上涨7%</blockquote>

2021-12-20

Tesla can buy for long term

2021-09-27

Top glove buy in zone 0.85 Will pump up to 1.00$TOP GLOVE CORPORATION BHD(BVA.SI)$

2021-09-24

Meli looks good for long-term investment. Buy at dip

抱歉，原内容已删除

2021-10-26

Good

抱歉，原内容已删除

2021-12-30

Good

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3582495099582633","uuid":"3582495099582633","gmtCreate":1619402398685,"gmtModify":1624602600715,"name":"fongms","pinyin":"fongms","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":8,"headSize":188,"tweetSize":21,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.01.24","exceedPercentage":"80.03%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.12.30","exceedPercentage":"93.86%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.16","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":692973818,"gmtCreate":1640835449206,"gmtModify":1640835449366,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692973818","repostId":"1100360696","repostType":4,"isVote":1,"tweetType":1,"viewCount":2441,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693375908,"gmtCreate":1639978751240,"gmtModify":1639978751354,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Tesla can buy for long term","listText":"Tesla can buy for long term","text":"Tesla can buy for long term","images":[{"img":"https://static.tigerbbs.com/1b84366b2a5685aed92cad7ddb219434","width":"1080","height":"2220"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693375908","isVote":1,"tweetType":1,"viewCount":2696,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":603328778,"gmtCreate":1638368688641,"gmtModify":1638368688845,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Pfizer","listText":"Pfizer","text":"Pfizer","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/603328778","repostId":"1119742422","repostType":4,"repost":{"id":"1119742422","kind":"news","pubTimestamp":1638368504,"share":"https://www.laohu8.com/m/news/1119742422?lang=zh_CN&edition=full","pubTime":"2021-12-01 22:21","market":"us","language":"en","title":"Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna或辉瑞股票：随着奥密克戎蔓延，该买哪一只？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1119742422","media":"TheStreet","summary":"Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks ","content":"<p>Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.</p><p><blockquote>自发现奥密克戎变种以来，对大流行的担忧再次出现，疫苗相关股票重新成为人们关注的焦点。今天，我们仔细看看Moderna和辉瑞的股票。</blockquote></p><p> COVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.</p><p><blockquote>新冠肺炎继续困扰市场。新变种奥密克戎重新引发了全世界对新的健康和经济危机的担忧，因为人们对这种变种如何影响接种疫苗和未接种疫苗的人知之甚少。</blockquote></p><p> The stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&amp;P 500&nbsp;dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock&nbsp;was up a more modest 2.5%.</p><p><blockquote>11月26日星期五，奥密克戎新闻频道播出后，股市遭到抛售。由于不确定性，标普500下跌2%。Moderna股票是为数不多的上涨者之一，该股在周五交易时段上涨了20%，而辉瑞股票则小幅上涨了2.5%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b55d87c377ec124bb84173bfb955b9fa\" tg-width=\"689\" tg-height=\"621\" width=\"100%\" height=\"auto\"><span>Figure 1: SPY, MRNA and PFE performance in the past 5-trading days.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：过去5个交易日的SPDR标普500指数ETF、MRNA和PFE表现。</span></p></blockquote></p><p> Between two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?</p><p><blockquote>在两家主要的COVID-19疫苗制造商之间，我们评估了Moderna和辉瑞的股票，并问自己：在奥密克戎恐惧挥之不去的情况下，哪一家更值得买入？</blockquote></p><p> <b>Wall Street is neutral on Moderna</b></p><p><blockquote><b>华尔街对Moderna持中立态度</b></blockquote></p><p> Moderna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.</p><p><blockquote>Moderna股票目前有13名分析师一致持有，平均目标价为298美元，这表明较当前水平下跌17%。华尔街的评估表明，股价可能已经领先于基本面，因为自COVID-19大流行开始以来，MRNA已上涨超过1,200%。</blockquote></p><p> The most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who&nbsp;reiterated&nbsp;his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.</p><p><blockquote>关于Moderna股票的最新报告来自Piper Sandler的Edward Tenthoff，他重申了买入建议，并在奥密克戎新闻的支持下预测目标价为348美元。分析师认为，该公司已为新变种的出现做好了准备，并且“非常适合快速更换新版本的刺突抗原”以制造新的COVID-19疫苗。</blockquote></p><p> Morgan Stanley’s Matthew Harrison&nbsp;reiterated&nbsp;his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.</p><p><blockquote>摩根士丹利的Matthew Harrison一周前重申了对MRNA的中性评级，目标价为313美元。该分析师提到，Moderna年底前流感疫苗数据的公布可能会成为该股的积极催化剂。如果结果是积极的，市场可能会预计长期流感和新冠疫苗收入约为100亿美元，使股价上涨10%。</blockquote></p><p> <b>Pfizer: moderate buy, but experts are skeptical</b></p><p><blockquote><b>辉瑞：适度买入，但专家持怀疑态度</b></blockquote></p><p> Wall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.</p><p><blockquote>根据股票评级，华尔街目前看好辉瑞。然而，平均价格目标共识表明，继11月上涨之后，估值可能会被拉低。根据13份报告，PFE给予适度买入建议，平均目标价为50美元。</blockquote></p><p> JPMorgan‘s Chris Schott&nbsp;raised&nbsp;the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.</p><p><blockquote>摩根大通的Chris Schott将辉瑞的目标价从42美元上调至53美元，并维持中性评级。Covid仍然是辉瑞故事的焦点，Comirnaty和Paxlovid的销售额“将明显超出预期”。虽然分析师认为该公司核心业务的上涨空间有限，但他不会对近期股价上涨感到惊讶奥密克戎头条新闻。</blockquote></p><p> The most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is&nbsp;skeptical&nbsp;on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.</p><p><blockquote>PFE的最新更新来自瑞穗证券的Vamil Divan。他对辉瑞股票持怀疑态度，并认为下行风险为16%。但这位分析师表示，奥密克戎可能会增加近期对辉瑞COVID-19疫苗的需求，尤其是加强剂量。</blockquote></p><p> <b>Wall Street Memes’ take</b></p><p><blockquote><b>华尔街模因的看法</b></blockquote></p><p> COVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.</p><p><blockquote>COVID-19疫苗制造商在短期内自然可能会从奥密克戎担忧中受益。例如，自2020年3月COVID-19大流行开始以来，Moderna的股价已上涨超过1,200%，而辉瑞股价同期上涨了79%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/198c43532bf2d097bc94e078b539a044\" tg-width=\"684\" tg-height=\"577\" width=\"100%\" height=\"auto\"><span>Figure 2: MRNA and PFE performance in the past 5-years.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：过去5年的MRNA和PFE表现。</span></p></blockquote></p><p> Pfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.</p><p><blockquote>辉瑞比Moderna大得多，市值为3000亿美元，而Moderna为1330亿美元。两家公司都拥有强大的疫苗管道和技术，但Moderna可能会从当前的大流行中受益，因为它更像是一只纯粹的股票。</blockquote></p><p> Due to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.</p><p><blockquote>由于商业模式多元化，我们认为MRNA是COVID-19发展的更好短期赌注。然而，出于同样的原因，并且由于2023年市盈率高达32倍，该股可能会更加波动，并存在更高的下行风险。另一方面，PFE可能是整个医疗保健领域更好的长期押注，特别是考虑到2023年去风险市盈率仅为13倍。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna或辉瑞股票：随着奥密克戎蔓延，该买哪一只？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna或辉瑞股票：随着奥密克戎蔓延，该买哪一只？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-12-01 22:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.</p><p><blockquote>自发现奥密克戎变种以来，对大流行的担忧再次出现，疫苗相关股票重新成为人们关注的焦点。今天，我们仔细看看Moderna和辉瑞的股票。</blockquote></p><p> COVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.</p><p><blockquote>新冠肺炎继续困扰市场。新变种奥密克戎重新引发了全世界对新的健康和经济危机的担忧，因为人们对这种变种如何影响接种疫苗和未接种疫苗的人知之甚少。</blockquote></p><p> The stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&amp;P 500&nbsp;dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock&nbsp;was up a more modest 2.5%.</p><p><blockquote>11月26日星期五，奥密克戎新闻频道播出后，股市遭到抛售。由于不确定性，标普500下跌2%。Moderna股票是为数不多的上涨者之一，该股在周五交易时段上涨了20%，而辉瑞股票则小幅上涨了2.5%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b55d87c377ec124bb84173bfb955b9fa\" tg-width=\"689\" tg-height=\"621\" width=\"100%\" height=\"auto\"><span>Figure 1: SPY, MRNA and PFE performance in the past 5-trading days.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：过去5个交易日的SPDR标普500指数ETF、MRNA和PFE表现。</span></p></blockquote></p><p> Between two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?</p><p><blockquote>在两家主要的COVID-19疫苗制造商之间，我们评估了Moderna和辉瑞的股票，并问自己：在奥密克戎恐惧挥之不去的情况下，哪一家更值得买入？</blockquote></p><p> <b>Wall Street is neutral on Moderna</b></p><p><blockquote><b>华尔街对Moderna持中立态度</b></blockquote></p><p> Moderna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.</p><p><blockquote>Moderna股票目前有13名分析师一致持有，平均目标价为298美元，这表明较当前水平下跌17%。华尔街的评估表明，股价可能已经领先于基本面，因为自COVID-19大流行开始以来，MRNA已上涨超过1,200%。</blockquote></p><p> The most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who&nbsp;reiterated&nbsp;his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.</p><p><blockquote>关于Moderna股票的最新报告来自Piper Sandler的Edward Tenthoff，他重申了买入建议，并在奥密克戎新闻的支持下预测目标价为348美元。分析师认为，该公司已为新变种的出现做好了准备，并且“非常适合快速更换新版本的刺突抗原”以制造新的COVID-19疫苗。</blockquote></p><p> Morgan Stanley’s Matthew Harrison&nbsp;reiterated&nbsp;his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.</p><p><blockquote>摩根士丹利的Matthew Harrison一周前重申了对MRNA的中性评级，目标价为313美元。该分析师提到，Moderna年底前流感疫苗数据的公布可能会成为该股的积极催化剂。如果结果是积极的，市场可能会预计长期流感和新冠疫苗收入约为100亿美元，使股价上涨10%。</blockquote></p><p> <b>Pfizer: moderate buy, but experts are skeptical</b></p><p><blockquote><b>辉瑞：适度买入，但专家持怀疑态度</b></blockquote></p><p> Wall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.</p><p><blockquote>根据股票评级，华尔街目前看好辉瑞。然而，平均价格目标共识表明，继11月上涨之后，估值可能会被拉低。根据13份报告，PFE给予适度买入建议，平均目标价为50美元。</blockquote></p><p> JPMorgan‘s Chris Schott&nbsp;raised&nbsp;the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.</p><p><blockquote>摩根大通的Chris Schott将辉瑞的目标价从42美元上调至53美元，并维持中性评级。Covid仍然是辉瑞故事的焦点，Comirnaty和Paxlovid的销售额“将明显超出预期”。虽然分析师认为该公司核心业务的上涨空间有限，但他不会对近期股价上涨感到惊讶奥密克戎头条新闻。</blockquote></p><p> The most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is&nbsp;skeptical&nbsp;on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.</p><p><blockquote>PFE的最新更新来自瑞穗证券的Vamil Divan。他对辉瑞股票持怀疑态度，并认为下行风险为16%。但这位分析师表示，奥密克戎可能会增加近期对辉瑞COVID-19疫苗的需求，尤其是加强剂量。</blockquote></p><p> <b>Wall Street Memes’ take</b></p><p><blockquote><b>华尔街模因的看法</b></blockquote></p><p> COVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.</p><p><blockquote>COVID-19疫苗制造商在短期内自然可能会从奥密克戎担忧中受益。例如，自2020年3月COVID-19大流行开始以来，Moderna的股价已上涨超过1,200%，而辉瑞股价同期上涨了79%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/198c43532bf2d097bc94e078b539a044\" tg-width=\"684\" tg-height=\"577\" width=\"100%\" height=\"auto\"><span>Figure 2: MRNA and PFE performance in the past 5-years.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：过去5年的MRNA和PFE表现。</span></p></blockquote></p><p> Pfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.</p><p><blockquote>辉瑞比Moderna大得多，市值为3000亿美元，而Moderna为1330亿美元。两家公司都拥有强大的疫苗管道和技术，但Moderna可能会从当前的大流行中受益，因为它更像是一只纯粹的股票。</blockquote></p><p> Due to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.</p><p><blockquote>由于商业模式多元化，我们认为MRNA是COVID-19发展的更好短期赌注。然而，出于同样的原因，并且由于2023年市盈率高达32倍，该股可能会更加波动，并存在更高的下行风险。另一方面，PFE可能是整个医疗保健领域更好的长期押注，特别是考虑到2023年去风险市盈率仅为13倍。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119742422","content_text":"Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.\nCOVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.\nThe stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&P 500 dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock was up a more modest 2.5%.\nFigure 1: SPY, MRNA and PFE performance in the past 5-trading days.\nBetween two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?\nWall Street is neutral on Moderna\nModerna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.\nThe most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who reiterated his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.\nMorgan Stanley’s Matthew Harrison reiterated his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.\nPfizer: moderate buy, but experts are skeptical\nWall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.\nJPMorgan‘s Chris Schott raised the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.\nThe most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is skeptical on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.\nWall Street Memes’ take\nCOVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.\nFigure 2: MRNA and PFE performance in the past 5-years.\nPfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.\nDue to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.","news_type":1,"symbols_score_info":{"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2012,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877648212,"gmtCreate":1637929743063,"gmtModify":1637929743124,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Its good","listText":"Its good","text":"Its good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877648212","repostId":"1145084508","repostType":4,"repost":{"id":"1145084508","kind":"news","pubTimestamp":1637929067,"share":"https://www.laohu8.com/m/news/1145084508?lang=zh_CN&edition=full","pubTime":"2021-11-26 20:17","market":"us","language":"en","title":"Fear, Not Calculated Trading, Is Behind Today’s Covid Market Crash<blockquote>今天新冠市场崩盘的背后是恐惧，而不是经过计算的交易</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1145084508","media":"Barrons","summary":"Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at ","content":"<p>Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at the stock market today will shatter that illusion.</p><p><blockquote>感恩节聚会可能会让许多人觉得疫情已经结束。看看今天的股市，这种幻想就会破灭。</blockquote></p><p> Concerns around a new, heavily-mutated variant of Covid-19 identified in South Africa have rocked investor confidence. Stocks are plunging around the world, oil prices are dropping, bond yields are sliding—even Bitcoin is feeling the heat. There is a broad reversion to frenzied, theme-based trading. Vaccine stocks and pandemic plays like Zoom are surging while airline stocks are falling.</p><p><blockquote>对南非发现的一种新的、严重突变的Covid-19变种的担忧动摇了投资者的信心。全球股市暴跌，油价下跌，债券收益率下滑——就连比特币也感受到了压力。疯狂的、基于主题的交易普遍回归。疫苗股和Zoom等流行病股正在飙升，而航空股却在下跌。</blockquote></p><p> What we are seeing is fear and uncertainty. Sell first, ask questions later. And low trading volumes globally due to the Thanksgiving holiday is likely exacerbating volatility.</p><p><blockquote>我们看到的是恐惧和不确定性。先卖，后问问题。感恩节假期导致的全球交易量低迷可能会加剧波动。</blockquote></p><p> What we are not seeing is markets intelligently pricing in the impact of this new development. Scientific experts have yet to draw conclusions about the mutation, known for now as B.1.1.529, and there are less than 100 confirmed cases.</p><p><blockquote>我们没有看到市场对这一新发展的影响进行明智的定价。科学专家尚未对目前被称为B.1.1.529的突变得出结论，确诊病例不到100例。</blockquote></p><p> That’s not to say fear is misplaced. Early indications are that B.1.1.529 is significantly different from other variants, and, truly, the worst case scenario is that it’s more deadly, contagious, and vaccine-resistant than what we’ve already faced.</p><p><blockquote>这并不是说恐惧是错误的。早期迹象表明，B.1.1.529与其他变种有很大不同，事实上，最糟糕的情况是它比我们已经面临的更具致命性、传染性和疫苗耐药性。</blockquote></p><p> But we don’t know that yet. Similar market shockwaves caused by the Delta variant over the summer eventually subsided. Though it led to a surge in cases around the world, modern science was able to tackle it and move on. Hopefully the same can be said of this variant.</p><p><blockquote>但我们还不知道。夏季德尔塔变异毒株引发的类似市场冲击波最终平息。尽管它导致了世界各地病例的激增，但现代科学能够解决它并继续前进。希望这种变体也是如此。</blockquote></p><p> But for now investors will have to put up with heightened uncertainty—the markets’ worst enemy.</p><p><blockquote>但目前投资者将不得不忍受不确定性的加剧——这是市场最大的敌人。</blockquote></p><p></p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fear, Not Calculated Trading, Is Behind Today’s Covid Market Crash<blockquote>今天新冠市场崩盘的背后是恐惧，而不是经过计算的交易</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFear, Not Calculated Trading, Is Behind Today’s Covid Market Crash<blockquote>今天新冠市场崩盘的背后是恐惧，而不是经过计算的交易</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-11-26 20:17</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at the stock market today will shatter that illusion.</p><p><blockquote>感恩节聚会可能会让许多人觉得疫情已经结束。看看今天的股市，这种幻想就会破灭。</blockquote></p><p> Concerns around a new, heavily-mutated variant of Covid-19 identified in South Africa have rocked investor confidence. Stocks are plunging around the world, oil prices are dropping, bond yields are sliding—even Bitcoin is feeling the heat. There is a broad reversion to frenzied, theme-based trading. Vaccine stocks and pandemic plays like Zoom are surging while airline stocks are falling.</p><p><blockquote>对南非发现的一种新的、严重突变的Covid-19变种的担忧动摇了投资者的信心。全球股市暴跌，油价下跌，债券收益率下滑——就连比特币也感受到了压力。疯狂的、基于主题的交易普遍回归。疫苗股和Zoom等流行病股正在飙升，而航空股却在下跌。</blockquote></p><p> What we are seeing is fear and uncertainty. Sell first, ask questions later. And low trading volumes globally due to the Thanksgiving holiday is likely exacerbating volatility.</p><p><blockquote>我们看到的是恐惧和不确定性。先卖，后问问题。感恩节假期导致的全球交易量低迷可能会加剧波动。</blockquote></p><p> What we are not seeing is markets intelligently pricing in the impact of this new development. Scientific experts have yet to draw conclusions about the mutation, known for now as B.1.1.529, and there are less than 100 confirmed cases.</p><p><blockquote>我们没有看到市场对这一新发展的影响进行明智的定价。科学专家尚未对目前被称为B.1.1.529的突变得出结论，确诊病例不到100例。</blockquote></p><p> That’s not to say fear is misplaced. Early indications are that B.1.1.529 is significantly different from other variants, and, truly, the worst case scenario is that it’s more deadly, contagious, and vaccine-resistant than what we’ve already faced.</p><p><blockquote>这并不是说恐惧是错误的。早期迹象表明，B.1.1.529与其他变种有很大不同，事实上，最糟糕的情况是它比我们已经面临的更具致命性、传染性和疫苗耐药性。</blockquote></p><p> But we don’t know that yet. Similar market shockwaves caused by the Delta variant over the summer eventually subsided. Though it led to a surge in cases around the world, modern science was able to tackle it and move on. Hopefully the same can be said of this variant.</p><p><blockquote>但我们还不知道。夏季德尔塔变异毒株引发的类似市场冲击波最终平息。尽管它导致了世界各地病例的激增，但现代科学能够解决它并继续前进。希望这种变体也是如此。</blockquote></p><p> But for now investors will have to put up with heightened uncertainty—the markets’ worst enemy.</p><p><blockquote>但目前投资者将不得不忍受不确定性的加剧——这是市场最大的敌人。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/articles/things-to-know-today-51637926639?mod=newsviewer_click\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.marketwatch.com/articles/things-to-know-today-51637926639?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1145084508","content_text":"Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at the stock market today will shatter that illusion.\nConcerns around a new, heavily-mutated variant of Covid-19 identified in South Africa have rocked investor confidence. Stocks are plunging around the world, oil prices are dropping, bond yields are sliding—even Bitcoin is feeling the heat. There is a broad reversion to frenzied, theme-based trading. Vaccine stocks and pandemic plays like Zoom are surging while airline stocks are falling.\nWhat we are seeing is fear and uncertainty. Sell first, ask questions later. And low trading volumes globally due to the Thanksgiving holiday is likely exacerbating volatility.\nWhat we are not seeing is markets intelligently pricing in the impact of this new development. Scientific experts have yet to draw conclusions about the mutation, known for now as B.1.1.529, and there are less than 100 confirmed cases.\nThat’s not to say fear is misplaced. Early indications are that B.1.1.529 is significantly different from other variants, and, truly, the worst case scenario is that it’s more deadly, contagious, and vaccine-resistant than what we’ve already faced.\nBut we don’t know that yet. Similar market shockwaves caused by the Delta variant over the summer eventually subsided. Though it led to a surge in cases around the world, modern science was able to tackle it and move on. Hopefully the same can be said of this variant.\nBut for now investors will have to put up with heightened uncertainty—the markets’ worst enemy.","news_type":1,"symbols_score_info":{".SPX":0.9,".DJI":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":1702,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875684296,"gmtCreate":1637643512247,"gmtModify":1637643512247,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Power","listText":"Power","text":"Power","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875684296","repostId":"2185808120","repostType":4,"repost":{"id":"2185808120","kind":"highlight","pubTimestamp":1637625517,"share":"https://www.laohu8.com/m/news/2185808120?lang=zh_CN&edition=full","pubTime":"2021-11-23 07:58","market":"us","language":"en","title":"Here's what Powell's nomination for 2nd term as Fed chairman means for markets<blockquote>这就是鲍威尔被提名连任美联储主席对市场的意义</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2185808120","media":"MarketWatch","summary":"Investors buoyed by 'continuity' as rival Brainard gets No. 2 spot, analysts say\nMarketWatch photo i","content":"<p>Investors buoyed by 'continuity' as rival Brainard gets No. 2 spot, analysts say</p><p><blockquote>分析师称，竞争对手布雷纳德获得第二名，投资者受到“连续性”的鼓舞</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/96d3ac1d26d057b0dd795501f245715c\" tg-width=\"700\" tg-height=\"487\" referrerpolicy=\"no-referrer\"><span>MarketWatch photo illustration/Getty Images</span></p><p><blockquote><p class=\"t-img-caption\"><span>MarketWatch照片插图/盖蒂图片社</span></p></blockquote></p><p> Stock-market investors appeared to be cheering President Joe Biden's decision Monday to nominate Jerome Powell to serve a second four-year term as Federal Reserve chairman.</p><p><blockquote>股市投资者似乎对乔·拜登总统周一提名杰罗姆·鲍威尔担任美联储主席第二个四年任期的决定感到高兴。</blockquote></p><p> The move had been widely anticipated by many, including betting markets.</p><p><blockquote>此举受到了包括博彩市场在内的许多人的广泛预期。</blockquote></p><p> Some questions about Powell being renamed to the helm of the central had been lingering as markets have been anxious about a surge in inflation in the aftermath of the pandemic, and some have argued that the central bank needs to employ more aggressive tactics or risk a 1970s-style surge in the price of goods and services amid supply-chain bottlenecks and a surge in demand.</p><p><blockquote>由于市场对大流行后通胀飙升感到焦虑，有关鲍威尔被重新任命为央行行长的一些问题一直挥之不去，一些人认为央行需要采取更激进的策略，否则就会面临20世纪70年代的风险。供应链瓶颈和需求激增导致商品和服务价格飙升。</blockquote></p><p> Biden's choice was seen as coming down to Powell or Fed Gov. Lael Brainard, who was viewed by analysts as potentially more dovish on inflation. Biden nominated Brainard to a term as vice chairwoman, succeeding Richard Clarida, whose term as the central bank's No. 2 official expires on Jan. 31.</p><p><blockquote>拜登的选择被视为取决于鲍威尔或美联储理事莱尔·布雷纳德，分析师认为后者在通胀问题上可能更加鸽派。拜登提名布雷纳德担任副主席，接替理查德·克拉里达，后者作为央行二号官员的任期将于1月31日到期。</blockquote></p><p> \"Both were great candidates but sticking with Powell provided valuable continuity as the Fed seeks to implement its new framework and continue to put employment alongside price stability as a core mandate,\" said Kathryn Judge, a professor at Columbia Law School. \"Particularly with recent price increases and growing concerns about inflation, there are benefits from standing by a trusted and widely respected leader.\"</p><p><blockquote>哥伦比亚法学院教授凯瑟琳·贾奇表示：“两人都是很好的候选人，但在美联储寻求实施其新框架并继续将就业和价格稳定作为核心任务时，坚持鲍威尔提供了宝贵的连续性。”“特别是在最近物价上涨和对通胀日益担忧的情况下，支持一位值得信赖且广受尊重的领导人是有好处的。”</blockquote></p><p> The Dow Jones Industrial Average , the S&amp;P 500 index and the Nasdaq Composite Index were all trading at or near records.</p><p><blockquote>道琼斯工业平均指数、标普500指数和纳斯达克综合指数均处于或接近历史新高。</blockquote></p><p> \"The reappointment of Chairman Powell is a very positive development for markets and the economy because it provides continuity at a critical time,\" wrote Chris Zaccarelli, chief investment officer for Independent Advisor Alliance, in emailed comments.</p><p><blockquote>独立顾问联盟首席投资官克里斯·扎卡雷利(Chris Zaccarelli)在电子邮件评论中写道：“鲍威尔主席的连任对市场和经济来说是一个非常积极的发展，因为它在关键时刻提供了连续性。”</blockquote></p><p> Powell's nomination also comes as the Fed has begun to taper its monthly purchases of Treasurys and mortgage-backed securities, on a timetable to wind down the program by June. Many also are anticipating that the Fed also might look to raise rates two or three times in 2022 as it attempts to rein in the surge in inflation and normalize interest rates in the aftermath of the worst pandemic in over a century.</p><p><blockquote>鲍威尔获得提名之际，美联储已开始缩减每月购买美国国债和抵押贷款支持证券的规模，并计划在6月前结束该计划。许多人还预计，美联储也可能在2022年加息两到三次，试图在一个多世纪以来最严重的疫情之后遏制通胀飙升并使利率正常化。</blockquote></p><p> \"The economy is experiencing an increase in inflation and the Fed has already taken steps to reduce their extraordinary stimulus measures (tapering), but they will need to move more quickly in addressing the inflation threats so that they don't become entrenched,\" Zaccarelli writes.</p><p><blockquote>“经济正在经历通胀上升，美联储已经采取措施减少非常规刺激措施（缩减），但他们需要更快地应对通胀威胁，以免它们变得根深蒂固，”扎卡雷利写道。</blockquote></p><p> The nominations end months of uncertainty and speculation about the leadership of the Fed at what is viewed as a crucial time in the recovery phase of the economy. Markets have been climbing to all-time highs even as yields for long-dated Treasurys were receding, suggesting that doubts remain about the economic outlook.</p><p><blockquote>在被视为经济复苏阶段的关键时刻，这些提名结束了数月来对美联储领导层的不确定性和猜测。尽管长期国债收益率下降，但市场仍在攀升至历史高位，这表明人们对经济前景仍存疑虑。</blockquote></p><p> The yield for the 10-year Treasury note was hovering just below 1.60%, after climbing over 5 basis points, while the S&amp;P 500 and the Nasdaq Composite indexes touched record intraday highs on Monday, the start of a historically solid period for equities in the week of Thanksgiving.</p><p><blockquote>10年期国债收益率在攀升超过5个基点后徘徊在略低于1.60%的水平，而标普500和纳斯达克综合指数周一触及盘中历史新高，这是股市历史上稳定时期的开始。感恩节的一周。</blockquote></p><p> On top of that, the Fed appears split about monetary-policy next steps, with some advocating for a go-slow approach to tapering and interest-rate raises, while others have been championing a faster rate of normalization moves to beat back inflation. The pace of consumer inflation over the past year marched to 6.2% in October from 5.4% in the prior month. That is more than triple the Federal Reserve's 2% target and is the highest rate since November 1990.</p><p><blockquote>最重要的是，美联储在货币政策下一步措施上似乎存在分歧，一些人主张采取缓慢的缩减和加息方式，而另一些人则主张加快正常化步伐以抑制通胀。过去一年的消费者通胀率从上月的5.4%升至10月份的6.2%。这是美联储2%目标的三倍多，也是自1990年11月以来的最高利率。</blockquote></p><p> The outlook for inflation seems uncertain, with some betting that pricing pressures will intensify, while others are making the case that inflation is in the process of peaking.</p><p><blockquote>通胀前景似乎不确定，一些人押注定价压力将加剧，而另一些人则认为通胀正在见顶。</blockquote></p><p> For his part, Powell has been viewed by supporters within the administration as a steady hand, The Wall Street Journal reported, citing sources, describing him as helping \"restore bipartisan support for the central bank one decade after its reputation was badly bruised by the 2008 financial crisis.\"</p><p><blockquote>《华尔街日报》援引消息人士的话报道称，鲍威尔被政府内部的支持者视为一只稳定的手，称他帮助“在央行声誉因2008年金融危机而严重受损十年后恢复了两党对央行的支持”。危机。”</blockquote></p><p> \"I have full confidence after their trial by fire over the last 20 months that Chair Powell and Dr. Brainard will provide the strong leadership our country needs,\" Biden said in a statement.</p><p><blockquote>拜登在一份声明中表示：“经过过去20个月的考验，我完全相信鲍威尔主席和布雷纳德博士将提供我们国家所需的强有力的领导。”</blockquote></p><p> The Senate is expected to confirm Powell, 68, before his first term expires in February.</p><p><blockquote>预计参议院将在68岁的鲍威尔的第一个任期于2月份到期之前确认他的身份。</blockquote></p><p> The Journal report said that putting Brainard as the Fed No. 2 represents a compromise for Biden with progressives in his party who had criticized Powell. Indeed, Democratic Sen. Elizabeth Warren of Massachusetts, accused Powell of watering down financial safeguards put in place after the panic of 2008 and called him a \"dangerous man.\"</p><p><blockquote>《华尔街日报》报道称，让布雷纳德担任美联储二号人物代表了拜登与党内批评鲍威尔的进步人士的妥协。事实上，马萨诸塞州民主党参议员伊丽莎白·沃伦(Elizabeth Warren)指责鲍威尔淡化了2008年恐慌后实施的金融保障措施，并称他为“危险人物”。</blockquote></p><p></p><p> Ryan Detrick, chief market strategist for LPL Financial, Powell's renomination represents \"one less worry now,\" for markets participants.</p><p><blockquote>LPL Financial首席市场策略师瑞安·德特里克(Ryan Detrick)表示，鲍威尔的再次提名代表着市场参与者“现在少了一个担忧”。</blockquote></p><p> Jeff Klingelhofer, co-head of investments at Thornburg Investment Management, said that \"with elevating inflation concerns on just about everyone's mind, Brainard would have been more difficult for the market to digest as chair.\"</p><p><blockquote>Thornburg Investment Management投资联席主管杰夫·克林格霍弗(Jeff Klingelhofer)表示，“随着几乎每个人都对通胀担忧加剧，布雷纳德担任主席会更难让市场消化。”</blockquote></p><p> \"Her appointment to vice chair offers Democrats a ballast to Powell and a likely regulatory win,\" he wrote, in emailed remarks.</p><p><blockquote>他在电子邮件中写道：“她被任命为副主席为民主党人提供了对鲍威尔的压舱石，并可能在监管方面取得胜利。”</blockquote></p><p> Biden will still oversee three other nominations for the Fed, including a replacement for Federal Reserve Gov. Randal Quarles, after a number of members announcement early retirements. Quarles said that he would resign at the end of December.</p><p><blockquote>在一些成员宣布提前退休后，拜登仍将监督美联储的其他三项提名，包括美联储理事兰德尔·夸尔斯的继任者。夸尔斯表示，他将在12月底辞职。</blockquote></p><p> Meanwhile, Powell's pick is likely to be a positive for digital assets like bitcoin , which the central banker has said that he would not move to restrict. The Fed also has been working on its own central bank digital currency, or CBDC.</p><p><blockquote>与此同时，鲍威尔的选择可能对比特币等数字资产有利，鲍威尔曾表示不会采取行动限制这些资产。美联储也一直在研究自己的央行数字货币（CBDC）。</blockquote></p><p> Bank stocks also were climbing reports, MarketWatch's Steve Gelsi. He notes that Brainard's name had come up as someone who might take bank regulator to replace the position being vacated by Trump nominee Quarles. The position could be vacated for some time, with potential candidates including Atlanta Fed President Raphael Bostic, former Fed Gov. Sarah Bloom Raskin and acting comptroller of the currency Michael Hsu in the mix.</p><p><blockquote>MarketWatch的Steve Gelsi报告称，银行股也在攀升。他指出，布雷纳德的名字可能会接替特朗普提名人夸尔斯空出的职位。该职位可能会空缺一段时间，潜在候选人包括亚特兰大联储主席拉斐尔·博斯蒂克、前美联储理事莎拉·布鲁姆·拉斯金和代理货币审计长迈克尔·许。</blockquote></p><p> The financial sectors&nbsp;rose 1.4% on Monday, among the best performing among the S&amp;P 500's 11 sectors on Monday. The SPDR S&amp;P Bank ETF&nbsp;rose 1.3%, while the Invesco KBW Bank ETF&nbsp;rose 1.8%, as Treasury yields climbed on the session.</p><p><blockquote>金融板块周一上涨1.4%，在周一标普500 11个板块中表现最好。SPDR S&amp;P Bank ETF上涨1.3%，Invesco KBW Bank ETF上涨1.8%，因国债收益率盘中攀升。</blockquote></p><p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's what Powell's nomination for 2nd term as Fed chairman means for markets<blockquote>这就是鲍威尔被提名连任美联储主席对市场的意义</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's what Powell's nomination for 2nd term as Fed chairman means for markets<blockquote>这就是鲍威尔被提名连任美联储主席对市场的意义</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MarketWatch</strong><span class=\"h-time small\">2021-11-23 07:58</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Investors buoyed by 'continuity' as rival Brainard gets No. 2 spot, analysts say</p><p><blockquote>分析师称，竞争对手布雷纳德获得第二名，投资者受到“连续性”的鼓舞</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/96d3ac1d26d057b0dd795501f245715c\" tg-width=\"700\" tg-height=\"487\" referrerpolicy=\"no-referrer\"><span>MarketWatch photo illustration/Getty Images</span></p><p><blockquote><p class=\"t-img-caption\"><span>MarketWatch照片插图/盖蒂图片社</span></p></blockquote></p><p> Stock-market investors appeared to be cheering President Joe Biden's decision Monday to nominate Jerome Powell to serve a second four-year term as Federal Reserve chairman.</p><p><blockquote>股市投资者似乎对乔·拜登总统周一提名杰罗姆·鲍威尔担任美联储主席第二个四年任期的决定感到高兴。</blockquote></p><p> The move had been widely anticipated by many, including betting markets.</p><p><blockquote>此举受到了包括博彩市场在内的许多人的广泛预期。</blockquote></p><p> Some questions about Powell being renamed to the helm of the central had been lingering as markets have been anxious about a surge in inflation in the aftermath of the pandemic, and some have argued that the central bank needs to employ more aggressive tactics or risk a 1970s-style surge in the price of goods and services amid supply-chain bottlenecks and a surge in demand.</p><p><blockquote>由于市场对大流行后通胀飙升感到焦虑，有关鲍威尔被重新任命为央行行长的一些问题一直挥之不去，一些人认为央行需要采取更激进的策略，否则就会面临20世纪70年代的风险。供应链瓶颈和需求激增导致商品和服务价格飙升。</blockquote></p><p> Biden's choice was seen as coming down to Powell or Fed Gov. Lael Brainard, who was viewed by analysts as potentially more dovish on inflation. Biden nominated Brainard to a term as vice chairwoman, succeeding Richard Clarida, whose term as the central bank's No. 2 official expires on Jan. 31.</p><p><blockquote>拜登的选择被视为取决于鲍威尔或美联储理事莱尔·布雷纳德，分析师认为后者在通胀问题上可能更加鸽派。拜登提名布雷纳德担任副主席，接替理查德·克拉里达，后者作为央行二号官员的任期将于1月31日到期。</blockquote></p><p> \"Both were great candidates but sticking with Powell provided valuable continuity as the Fed seeks to implement its new framework and continue to put employment alongside price stability as a core mandate,\" said Kathryn Judge, a professor at Columbia Law School. \"Particularly with recent price increases and growing concerns about inflation, there are benefits from standing by a trusted and widely respected leader.\"</p><p><blockquote>哥伦比亚法学院教授凯瑟琳·贾奇表示：“两人都是很好的候选人，但在美联储寻求实施其新框架并继续将就业和价格稳定作为核心任务时，坚持鲍威尔提供了宝贵的连续性。”“特别是在最近物价上涨和对通胀日益担忧的情况下，支持一位值得信赖且广受尊重的领导人是有好处的。”</blockquote></p><p> The Dow Jones Industrial Average , the S&amp;P 500 index and the Nasdaq Composite Index were all trading at or near records.</p><p><blockquote>道琼斯工业平均指数、标普500指数和纳斯达克综合指数均处于或接近历史新高。</blockquote></p><p> \"The reappointment of Chairman Powell is a very positive development for markets and the economy because it provides continuity at a critical time,\" wrote Chris Zaccarelli, chief investment officer for Independent Advisor Alliance, in emailed comments.</p><p><blockquote>独立顾问联盟首席投资官克里斯·扎卡雷利(Chris Zaccarelli)在电子邮件评论中写道：“鲍威尔主席的连任对市场和经济来说是一个非常积极的发展，因为它在关键时刻提供了连续性。”</blockquote></p><p> Powell's nomination also comes as the Fed has begun to taper its monthly purchases of Treasurys and mortgage-backed securities, on a timetable to wind down the program by June. Many also are anticipating that the Fed also might look to raise rates two or three times in 2022 as it attempts to rein in the surge in inflation and normalize interest rates in the aftermath of the worst pandemic in over a century.</p><p><blockquote>鲍威尔获得提名之际，美联储已开始缩减每月购买美国国债和抵押贷款支持证券的规模，并计划在6月前结束该计划。许多人还预计，美联储也可能在2022年加息两到三次，试图在一个多世纪以来最严重的疫情之后遏制通胀飙升并使利率正常化。</blockquote></p><p> \"The economy is experiencing an increase in inflation and the Fed has already taken steps to reduce their extraordinary stimulus measures (tapering), but they will need to move more quickly in addressing the inflation threats so that they don't become entrenched,\" Zaccarelli writes.</p><p><blockquote>“经济正在经历通胀上升，美联储已经采取措施减少非常规刺激措施（缩减），但他们需要更快地应对通胀威胁，以免它们变得根深蒂固，”扎卡雷利写道。</blockquote></p><p> The nominations end months of uncertainty and speculation about the leadership of the Fed at what is viewed as a crucial time in the recovery phase of the economy. Markets have been climbing to all-time highs even as yields for long-dated Treasurys were receding, suggesting that doubts remain about the economic outlook.</p><p><blockquote>在被视为经济复苏阶段的关键时刻，这些提名结束了数月来对美联储领导层的不确定性和猜测。尽管长期国债收益率下降，但市场仍在攀升至历史高位，这表明人们对经济前景仍存疑虑。</blockquote></p><p> The yield for the 10-year Treasury note was hovering just below 1.60%, after climbing over 5 basis points, while the S&amp;P 500 and the Nasdaq Composite indexes touched record intraday highs on Monday, the start of a historically solid period for equities in the week of Thanksgiving.</p><p><blockquote>10年期国债收益率在攀升超过5个基点后徘徊在略低于1.60%的水平，而标普500和纳斯达克综合指数周一触及盘中历史新高，这是股市历史上稳定时期的开始。感恩节的一周。</blockquote></p><p> On top of that, the Fed appears split about monetary-policy next steps, with some advocating for a go-slow approach to tapering and interest-rate raises, while others have been championing a faster rate of normalization moves to beat back inflation. The pace of consumer inflation over the past year marched to 6.2% in October from 5.4% in the prior month. That is more than triple the Federal Reserve's 2% target and is the highest rate since November 1990.</p><p><blockquote>最重要的是，美联储在货币政策下一步措施上似乎存在分歧，一些人主张采取缓慢的缩减和加息方式，而另一些人则主张加快正常化步伐以抑制通胀。过去一年的消费者通胀率从上月的5.4%升至10月份的6.2%。这是美联储2%目标的三倍多，也是自1990年11月以来的最高利率。</blockquote></p><p> The outlook for inflation seems uncertain, with some betting that pricing pressures will intensify, while others are making the case that inflation is in the process of peaking.</p><p><blockquote>通胀前景似乎不确定，一些人押注定价压力将加剧，而另一些人则认为通胀正在见顶。</blockquote></p><p> For his part, Powell has been viewed by supporters within the administration as a steady hand, The Wall Street Journal reported, citing sources, describing him as helping \"restore bipartisan support for the central bank one decade after its reputation was badly bruised by the 2008 financial crisis.\"</p><p><blockquote>《华尔街日报》援引消息人士的话报道称，鲍威尔被政府内部的支持者视为一只稳定的手，称他帮助“在央行声誉因2008年金融危机而严重受损十年后恢复了两党对央行的支持”。危机。”</blockquote></p><p> \"I have full confidence after their trial by fire over the last 20 months that Chair Powell and Dr. Brainard will provide the strong leadership our country needs,\" Biden said in a statement.</p><p><blockquote>拜登在一份声明中表示：“经过过去20个月的考验，我完全相信鲍威尔主席和布雷纳德博士将提供我们国家所需的强有力的领导。”</blockquote></p><p> The Senate is expected to confirm Powell, 68, before his first term expires in February.</p><p><blockquote>预计参议院将在68岁的鲍威尔的第一个任期于2月份到期之前确认他的身份。</blockquote></p><p> The Journal report said that putting Brainard as the Fed No. 2 represents a compromise for Biden with progressives in his party who had criticized Powell. Indeed, Democratic Sen. Elizabeth Warren of Massachusetts, accused Powell of watering down financial safeguards put in place after the panic of 2008 and called him a \"dangerous man.\"</p><p><blockquote>《华尔街日报》报道称，让布雷纳德担任美联储二号人物代表了拜登与党内批评鲍威尔的进步人士的妥协。事实上，马萨诸塞州民主党参议员伊丽莎白·沃伦(Elizabeth Warren)指责鲍威尔淡化了2008年恐慌后实施的金融保障措施，并称他为“危险人物”。</blockquote></p><p></p><p> Ryan Detrick, chief market strategist for LPL Financial, Powell's renomination represents \"one less worry now,\" for markets participants.</p><p><blockquote>LPL Financial首席市场策略师瑞安·德特里克(Ryan Detrick)表示，鲍威尔的再次提名代表着市场参与者“现在少了一个担忧”。</blockquote></p><p> Jeff Klingelhofer, co-head of investments at Thornburg Investment Management, said that \"with elevating inflation concerns on just about everyone's mind, Brainard would have been more difficult for the market to digest as chair.\"</p><p><blockquote>Thornburg Investment Management投资联席主管杰夫·克林格霍弗(Jeff Klingelhofer)表示，“随着几乎每个人都对通胀担忧加剧，布雷纳德担任主席会更难让市场消化。”</blockquote></p><p> \"Her appointment to vice chair offers Democrats a ballast to Powell and a likely regulatory win,\" he wrote, in emailed remarks.</p><p><blockquote>他在电子邮件中写道：“她被任命为副主席为民主党人提供了对鲍威尔的压舱石，并可能在监管方面取得胜利。”</blockquote></p><p> Biden will still oversee three other nominations for the Fed, including a replacement for Federal Reserve Gov. Randal Quarles, after a number of members announcement early retirements. Quarles said that he would resign at the end of December.</p><p><blockquote>在一些成员宣布提前退休后，拜登仍将监督美联储的其他三项提名，包括美联储理事兰德尔·夸尔斯的继任者。夸尔斯表示，他将在12月底辞职。</blockquote></p><p> Meanwhile, Powell's pick is likely to be a positive for digital assets like bitcoin , which the central banker has said that he would not move to restrict. The Fed also has been working on its own central bank digital currency, or CBDC.</p><p><blockquote>与此同时，鲍威尔的选择可能对比特币等数字资产有利，鲍威尔曾表示不会采取行动限制这些资产。美联储也一直在研究自己的央行数字货币（CBDC）。</blockquote></p><p> Bank stocks also were climbing reports, MarketWatch's Steve Gelsi. He notes that Brainard's name had come up as someone who might take bank regulator to replace the position being vacated by Trump nominee Quarles. The position could be vacated for some time, with potential candidates including Atlanta Fed President Raphael Bostic, former Fed Gov. Sarah Bloom Raskin and acting comptroller of the currency Michael Hsu in the mix.</p><p><blockquote>MarketWatch的Steve Gelsi报告称，银行股也在攀升。他指出，布雷纳德的名字可能会接替特朗普提名人夸尔斯空出的职位。该职位可能会空缺一段时间，潜在候选人包括亚特兰大联储主席拉斐尔·博斯蒂克、前美联储理事莎拉·布鲁姆·拉斯金和代理货币审计长迈克尔·许。</blockquote></p><p> The financial sectors&nbsp;rose 1.4% on Monday, among the best performing among the S&amp;P 500's 11 sectors on Monday. The SPDR S&amp;P Bank ETF&nbsp;rose 1.3%, while the Invesco KBW Bank ETF&nbsp;rose 1.8%, as Treasury yields climbed on the session.</p><p><blockquote>金融板块周一上涨1.4%，在周一标普500 11个板块中表现最好。SPDR S&amp;P Bank ETF上涨1.3%，Invesco KBW Bank ETF上涨1.8%，因国债收益率盘中攀升。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/heres-what-powells-nomination-for-2nd-term-as-fed-chairman-means-for-markets-11637599539?mod=home-page\">MarketWatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index","XLF":"金融ETF"},"source_url":"https://www.marketwatch.com/story/heres-what-powells-nomination-for-2nd-term-as-fed-chairman-means-for-markets-11637599539?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2185808120","content_text":"Investors buoyed by 'continuity' as rival Brainard gets No. 2 spot, analysts say\nMarketWatch photo illustration/Getty Images\nStock-market investors appeared to be cheering President Joe Biden's decision Monday to nominate Jerome Powell to serve a second four-year term as Federal Reserve chairman.\nThe move had been widely anticipated by many, including betting markets.\nSome questions about Powell being renamed to the helm of the central had been lingering as markets have been anxious about a surge in inflation in the aftermath of the pandemic, and some have argued that the central bank needs to employ more aggressive tactics or risk a 1970s-style surge in the price of goods and services amid supply-chain bottlenecks and a surge in demand.\nBiden's choice was seen as coming down to Powell or Fed Gov. Lael Brainard, who was viewed by analysts as potentially more dovish on inflation. Biden nominated Brainard to a term as vice chairwoman, succeeding Richard Clarida, whose term as the central bank's No. 2 official expires on Jan. 31.\n\"Both were great candidates but sticking with Powell provided valuable continuity as the Fed seeks to implement its new framework and continue to put employment alongside price stability as a core mandate,\" said Kathryn Judge, a professor at Columbia Law School. \"Particularly with recent price increases and growing concerns about inflation, there are benefits from standing by a trusted and widely respected leader.\"\nThe Dow Jones Industrial Average , the S&P 500 index and the Nasdaq Composite Index were all trading at or near records.\n\"The reappointment of Chairman Powell is a very positive development for markets and the economy because it provides continuity at a critical time,\" wrote Chris Zaccarelli, chief investment officer for Independent Advisor Alliance, in emailed comments.\nPowell's nomination also comes as the Fed has begun to taper its monthly purchases of Treasurys and mortgage-backed securities, on a timetable to wind down the program by June. Many also are anticipating that the Fed also might look to raise rates two or three times in 2022 as it attempts to rein in the surge in inflation and normalize interest rates in the aftermath of the worst pandemic in over a century.\n\"The economy is experiencing an increase in inflation and the Fed has already taken steps to reduce their extraordinary stimulus measures (tapering), but they will need to move more quickly in addressing the inflation threats so that they don't become entrenched,\" Zaccarelli writes.\nThe nominations end months of uncertainty and speculation about the leadership of the Fed at what is viewed as a crucial time in the recovery phase of the economy. Markets have been climbing to all-time highs even as yields for long-dated Treasurys were receding, suggesting that doubts remain about the economic outlook.\nThe yield for the 10-year Treasury note was hovering just below 1.60%, after climbing over 5 basis points, while the S&P 500 and the Nasdaq Composite indexes touched record intraday highs on Monday, the start of a historically solid period for equities in the week of Thanksgiving.\nOn top of that, the Fed appears split about monetary-policy next steps, with some advocating for a go-slow approach to tapering and interest-rate raises, while others have been championing a faster rate of normalization moves to beat back inflation. The pace of consumer inflation over the past year marched to 6.2% in October from 5.4% in the prior month. That is more than triple the Federal Reserve's 2% target and is the highest rate since November 1990.\nThe outlook for inflation seems uncertain, with some betting that pricing pressures will intensify, while others are making the case that inflation is in the process of peaking.\nFor his part, Powell has been viewed by supporters within the administration as a steady hand, The Wall Street Journal reported, citing sources, describing him as helping \"restore bipartisan support for the central bank one decade after its reputation was badly bruised by the 2008 financial crisis.\"\n\"I have full confidence after their trial by fire over the last 20 months that Chair Powell and Dr. Brainard will provide the strong leadership our country needs,\" Biden said in a statement.\nThe Senate is expected to confirm Powell, 68, before his first term expires in February.\nThe Journal report said that putting Brainard as the Fed No. 2 represents a compromise for Biden with progressives in his party who had criticized Powell. Indeed, Democratic Sen. Elizabeth Warren of Massachusetts, accused Powell of watering down financial safeguards put in place after the panic of 2008 and called him a \"dangerous man.\"\nRyan Detrick, chief market strategist for LPL Financial, Powell's renomination represents \"one less worry now,\" for markets participants.\nJeff Klingelhofer, co-head of investments at Thornburg Investment Management, said that \"with elevating inflation concerns on just about everyone's mind, Brainard would have been more difficult for the market to digest as chair.\"\n\"Her appointment to vice chair offers Democrats a ballast to Powell and a likely regulatory win,\" he wrote, in emailed remarks.\nBiden will still oversee three other nominations for the Fed, including a replacement for Federal Reserve Gov. Randal Quarles, after a number of members announcement early retirements. Quarles said that he would resign at the end of December.\nMeanwhile, Powell's pick is likely to be a positive for digital assets like bitcoin , which the central banker has said that he would not move to restrict. The Fed also has been working on its own central bank digital currency, or CBDC.\nBank stocks also were climbing reports, MarketWatch's Steve Gelsi. He notes that Brainard's name had come up as someone who might take bank regulator to replace the position being vacated by Trump nominee Quarles. The position could be vacated for some time, with potential candidates including Atlanta Fed President Raphael Bostic, former Fed Gov. Sarah Bloom Raskin and acting comptroller of the currency Michael Hsu in the mix.\nThe financial sectors rose 1.4% on Monday, among the best performing among the S&P 500's 11 sectors on Monday. The SPDR S&P Bank ETF rose 1.3%, while the Invesco KBW Bank ETF rose 1.8%, as Treasury yields climbed on the session.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"XLF":0.9}},"isVote":1,"tweetType":1,"viewCount":2655,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847705383,"gmtCreate":1636552134922,"gmtModify":1636552135082,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847705383","repostId":"1112315702","repostType":4,"repost":{"id":"1112315702","kind":"news","pubTimestamp":1636551867,"share":"https://www.laohu8.com/m/news/1112315702?lang=zh_CN&edition=full","pubTime":"2021-11-10 21:44","market":"us","language":"en","title":"Why Are PubMatic Shares Trading Higher Premarket?<blockquote>为什么PubMatic股价盘前走高？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1112315702","media":"Benzinga","summary":"Oppenheimer analyst Jason Helfstein raised the price target on PubMatic Inc to $50 from $45, implyin","content":"<p><div> Oppenheimer analyst Jason Helfstein raised the price target on PubMatic Inc to $50 from $45, implying a 55.7% upside, and reiterated an Outperform. The company's Q3 results and guidance suggest it is ...</p><p><blockquote><div>Oppenheimer分析师Jason Helfstein将PubMatic Inc的目标股价从45美元上调至50美元，意味着上涨55.7%，并重申跑赢大盘。该公司第三季度的业绩和指引表明……</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/earnings/21/11/24007317/why-are-pubmatic-shares-trading-higher-premarket\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/earnings/21/11/24007317/why-are-pubmatic-shares-trading-higher-premarket\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Are PubMatic Shares Trading Higher Premarket?<blockquote>为什么PubMatic股价盘前走高？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Are PubMatic Shares Trading Higher Premarket?<blockquote>为什么PubMatic股价盘前走高？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-11-10 21:44</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Oppenheimer analyst Jason Helfstein raised the price target on PubMatic Inc to $50 from $45, implying a 55.7% upside, and reiterated an Outperform. The company's Q3 results and guidance suggest it is ...</p><p><blockquote><div>Oppenheimer分析师Jason Helfstein将PubMatic Inc的目标股价从45美元上调至50美元，意味着上涨55.7%，并重申跑赢大盘。该公司第三季度的业绩和指引表明……</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/earnings/21/11/24007317/why-are-pubmatic-shares-trading-higher-premarket\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/earnings/21/11/24007317/why-are-pubmatic-shares-trading-higher-premarket\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/news/earnings/21/11/24007317/why-are-pubmatic-shares-trading-higher-premarket\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PUBM":"PubMatic, Inc."},"source_url":"https://www.benzinga.com/news/earnings/21/11/24007317/why-are-pubmatic-shares-trading-higher-premarket","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1112315702","content_text":"Oppenheimer analyst Jason Helfstein raised the price target on PubMatic Inc to $50 from $45, implying a 55.7% upside, and reiterated an Outperform.\nThe company's Q3 results and guidance suggest it is gaining share and has been able to turn Apple Inc's (NASDAQ: AAPL) Identifier for Advertisers and advertisers to focus on the removal of cookies into a tailwind.\nThe analyst believes PubMatic is \"successfully moving closer to advertisers and agencies.\"\nPubMatic reported third-quarter FY21 revenue growth of 54% year-on-year to $58.1 million.\n\"This quarter marks our fourth consecutive quarter of organic revenue growth above 50% and adjusted EBITDA margin over 30%,\" CEO Rajeev Goel said.\nPubMatic processed 23.9 trillion impressions in Q3, a 103% increase Y/Y as publishers continued to expand their inventory on the PubMatic platform.\nRevenue from fast-growing advertising formats mobile and omnichannel video, which includes CTV, grew 64% Y/Y.\nRevenue from CTV grew by over seven times Y/Y. PubMatic programmatically monetized CTV inventory from 154 publishers, up from 114 publishers in Q2 of 2021.\nOutlook: PubMatic sees Q4 revenue of $74 million - $76 million, above the consensus of $62.2 million.\nPubMatic raised FY21 revenue outlook to $225 million - $227 million (previously $205 million - $209 million), above the consensus of $208 million.\nPubMatic sees FY22 revenue of at least $281 million, above the consensus of $260.22 million.\nPrice Action:PUBM shares traded higher by 24.5% at $39.98 in the premarket session on the last check Wednesday.","news_type":1,"symbols_score_info":{"PUBM":0.9}},"isVote":1,"tweetType":1,"viewCount":2229,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856734075,"gmtCreate":1635212355063,"gmtModify":1635212355180,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856734075","repostId":"1184179575","repostType":2,"isVote":1,"tweetType":1,"viewCount":2407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821988958,"gmtCreate":1633686357602,"gmtModify":1633686357720,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Its a good start","listText":"Its a good start","text":"Its a good start","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/821988958","repostId":"1108043623","repostType":4,"repost":{"id":"1108043623","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633682657,"share":"https://www.laohu8.com/m/news/1108043623?lang=zh_CN&edition=full","pubTime":"2021-10-08 16:44","market":"us","language":"en","title":"Vaxart gained 7% in premarket trading<blockquote>Vaxart在盘前交易中上涨7%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1108043623","media":"Tiger Newspress","summary":"(Oct 8) Vaxart, Inc shares are up 7% in premarket trading after publishing results in an animal mode","content":"<p>(Oct 8)&nbsp;<b><a href=\"https://laohu8.com/S/VXRT\">Vaxart, Inc</a></b> shares are&nbsp;up 7%&nbsp;in premarket trading after&nbsp;publishing results in an animal model that its COVID-19 vaccine pill can reduce airborne transmission of SARS-CoV-2.</p><p><blockquote>（10月8日）<b><a href=\"https://laohu8.com/S/VXRT\">Vaxart公司</a></b>在公布动物模型结果表明其COVID-19疫苗可以减少新型冠状病毒病毒的空气传播后，该公司股价在盘前交易中上涨7%。</blockquote></p><p> Hamsters were vaccinated orally or intranasally with the vaccine candidate and then exposed to high levels of the COVID-19 virus to promote vaccine breakthrough. Vaccinated hamsters cleared the virus in the nose and lungs quickly.</p><p><blockquote>仓鼠口服或鼻内接种候选疫苗，然后暴露于高水平的新冠肺炎病毒，以促进疫苗突破。接种疫苗的仓鼠很快清除了鼻子和肺部的病毒。</blockquote></p><p> But before clearing the infection, vaccinated hamsters were exposed to unvaccinated hamsters. The vaccinated hamsters infected fewer hamsters and created less severe clinical symptoms than did unvaccinated hamsters.</p><p><blockquote>但在清除感染之前，接种疫苗的仓鼠暴露于未接种疫苗的仓鼠。与未接种疫苗的仓鼠相比，接种疫苗的仓鼠感染的仓鼠更少，产生的临床症状也更轻。</blockquote></p><p> Results were published in&nbsp;BioRxiv, and have yet to be peer-reviewed.</p><p><blockquote>结果发表在BioRxiv上，尚未经过同行评审。</blockquote></p><p> Vaxart yesterday&nbsp;began recruitment in a phase 2 trial of the oral COVID vaccine.</p><p><blockquote>Vaxart昨天开始招募口服新冠疫苗的2期试验。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1ebf72c0d5d89ceb2daa800e4fd962dc\" tg-width=\"1176\" tg-height=\"569\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaxart gained 7% in premarket trading<blockquote>Vaxart在盘前交易中上涨7%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaxart gained 7% in premarket trading<blockquote>Vaxart在盘前交易中上涨7%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-10-08 16:44</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>(Oct 8)&nbsp;<b><a href=\"https://laohu8.com/S/VXRT\">Vaxart, Inc</a></b> shares are&nbsp;up 7%&nbsp;in premarket trading after&nbsp;publishing results in an animal model that its COVID-19 vaccine pill can reduce airborne transmission of SARS-CoV-2.</p><p><blockquote>（10月8日）<b><a href=\"https://laohu8.com/S/VXRT\">Vaxart公司</a></b>在公布动物模型结果表明其COVID-19疫苗可以减少新型冠状病毒病毒的空气传播后，该公司股价在盘前交易中上涨7%。</blockquote></p><p> Hamsters were vaccinated orally or intranasally with the vaccine candidate and then exposed to high levels of the COVID-19 virus to promote vaccine breakthrough. Vaccinated hamsters cleared the virus in the nose and lungs quickly.</p><p><blockquote>仓鼠口服或鼻内接种候选疫苗，然后暴露于高水平的新冠肺炎病毒，以促进疫苗突破。接种疫苗的仓鼠很快清除了鼻子和肺部的病毒。</blockquote></p><p> But before clearing the infection, vaccinated hamsters were exposed to unvaccinated hamsters. The vaccinated hamsters infected fewer hamsters and created less severe clinical symptoms than did unvaccinated hamsters.</p><p><blockquote>但在清除感染之前，接种疫苗的仓鼠暴露于未接种疫苗的仓鼠。与未接种疫苗的仓鼠相比，接种疫苗的仓鼠感染的仓鼠更少，产生的临床症状也更轻。</blockquote></p><p> Results were published in&nbsp;BioRxiv, and have yet to be peer-reviewed.</p><p><blockquote>结果发表在BioRxiv上，尚未经过同行评审。</blockquote></p><p> Vaxart yesterday&nbsp;began recruitment in a phase 2 trial of the oral COVID vaccine.</p><p><blockquote>Vaxart昨天开始招募口服新冠疫苗的2期试验。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1ebf72c0d5d89ceb2daa800e4fd962dc\" tg-width=\"1176\" tg-height=\"569\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VXRT":"Vaxart, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108043623","content_text":"(Oct 8) Vaxart, Inc shares are up 7% in premarket trading after publishing results in an animal model that its COVID-19 vaccine pill can reduce airborne transmission of SARS-CoV-2.\nHamsters were vaccinated orally or intranasally with the vaccine candidate and then exposed to high levels of the COVID-19 virus to promote vaccine breakthrough. Vaccinated hamsters cleared the virus in the nose and lungs quickly.\nBut before clearing the infection, vaccinated hamsters were exposed to unvaccinated hamsters. The vaccinated hamsters infected fewer hamsters and created less severe clinical symptoms than did unvaccinated hamsters.\nResults were published in BioRxiv, and have yet to be peer-reviewed.\nVaxart yesterday began recruitment in a phase 2 trial of the oral COVID vaccine.","news_type":1,"symbols_score_info":{"VXRT":0.9}},"isVote":1,"tweetType":1,"viewCount":1916,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823045212,"gmtCreate":1633567751384,"gmtModify":1633567923249,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823045212","repostId":"2173794328","repostType":4,"isVote":1,"tweetType":1,"viewCount":3801,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823046429,"gmtCreate":1633567652267,"gmtModify":1633567652395,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Like please&nbsp;","listText":"Like please&nbsp;","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/823046429","repostId":"2173948202","repostType":4,"isVote":1,"tweetType":1,"viewCount":2600,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823046037,"gmtCreate":1633567619230,"gmtModify":1633567619317,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"May be","listText":"May be","text":"May be","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823046037","repostId":"1165951132","repostType":4,"repost":{"id":"1165951132","kind":"news","pubTimestamp":1633566955,"share":"https://www.laohu8.com/m/news/1165951132?lang=zh_CN&edition=full","pubTime":"2021-10-07 08:35","market":"us","language":"en","title":"Apple Stock: 3 Reasons Why The Selloff Is An Opportunity<blockquote>苹果股票：抛售是机会的3个原因</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1165951132","media":"TheStreet","summary":"Apple stock continues to hover around $140 apiece, the same levels of three months ago. The Apple Maven presents three reasons why shares may climb from here in the foreseeable future.As Apple stock dips to just north of $140 apiece, many may feel uneasy holding shares when momentum is so unfavorable. But there are at least three reasons, all supported by investment experts and the Apple Maven, that suggest that buying AAPL now may be the right move.Today, the Apple Maven looks at what I conside","content":"<p>Apple stock continues to hover around $140 apiece, the same levels of three months ago. The Apple Maven presents three reasons why shares may climb from here in the foreseeable future.</p><p><blockquote>苹果股价继续徘徊在每股140美元左右，与三个月前的水平相同。这位苹果专家提出了在可预见的未来股价可能会从这里攀升的三个原因。</blockquote></p><p> As Apple stock&nbsp;dips to just north of $140 apiece, many may feel uneasy holding shares when momentum is so unfavorable. But there are at least three reasons, all supported by investment experts and the Apple Maven, that suggest that buying AAPL now may be the right move.</p><p><blockquote>随着苹果股价跌至每股140美元以上，在势头如此不利的情况下，许多人可能会对持有股票感到不安。但至少有三个原因，都得到了投资专家和苹果专家的支持，表明现在收购苹果公司可能是正确的举动。</blockquote></p><p> Today, the Apple Maven looks at what I consider to be the three key pillars of the short-term bullish case on the Cupertino-based company’s stock.</p><p><blockquote>今天，这位苹果专家探讨了我认为短期看涨这家总部位于库比蒂诺的公司股票的三个关键支柱。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6a988efddcce991fe9a4da989de37cf2\" tg-width=\"1240\" tg-height=\"827\" width=\"100%\" height=\"auto\"><span>Figure 1: Apple logo.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：苹果标志。</span></p></blockquote></p><p> <b>#1. Selloff is not about Apple</b></p><p><blockquote><b>#1.抛售与苹果无关</b></blockquote></p><p> Few will argue that Apple’s quick 10% drop from the September 7 all-time high had anything to do with the company’s fundamentals. In fact,as I have recently presented, the core of Apple’s business has been in great shape: the iPhone 13 is proving to be a bigger deal than many previously expected.</p><p><blockquote>很少有人会认为苹果从9月7日的历史高点快速下跌10%与该公司的基本面有关。事实上，正如我最近介绍的那样，苹果业务的核心状况非常好：事实证明，iPhone 13比许多人之前预期的要大。</blockquote></p><p> Evidence that Apple’s performance is very likely unrelated to the recent share price decline can also be found in analysts’ expectations. Over the past 90 days, while AAPL price stayed flat at around $140 per share, 2021 EPS projections climbed more than 40 cents. Apply a conservative earnings multiple of 25 times to this delta, and we are looking at over $10 in per-share value that never materialized.</p><p><blockquote>苹果的业绩很可能与近期股价下跌无关的证据也可以在分析师的预期中找到。过去90天，虽然AAPL价格持平于每股140美元左右，但2021年每股收益预测却攀升了40多美分。将25倍的保守市盈率应用于该delta，我们看到的每股价值超过10美元，但从未实现。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f06a897cf92907ec889996f34932ed22\" tg-width=\"878\" tg-height=\"223\" width=\"100%\" height=\"auto\"><span>Figure 2: AAPL EPS trend.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：AAPL每股收益趋势。</span></p></blockquote></p><p> If the recent pullback in AAPL happened despite deterioration in fundamentals, then I find it reasonable to expect Apple stock to rebound in the foreseeable future. This also seems to be the opinion of Wedbush’s Dan Ives, who recently&nbsp;said&nbsp;the following:</p><p><blockquote>如果苹果公司最近的回调是在基本面恶化的情况下发生的，那么我认为有理由预期苹果股票在可预见的未来反弹。这似乎也是Wedbush的Dan Ives的观点，他最近发表了以下言论：</blockquote></p><p>   “We continue to believe this pressure on the tech sector is short-lived with our belief that tech stocks will be up 10%+ into year-end. The tech growth stories are being massively underestimated by the Street in our opinion, with 3Q earnings a major positive catalyst for the tech sector looking ahead.”  <b>#2. History says “buy dips”</b></p><p><blockquote>“我们仍然认为科技股面临的压力是短暂的，我们相信科技股到年底将上涨10%以上。我们认为，华尔街严重低估了科技股的增长故事，第三季度盈利是科技行业未来的主要积极催化剂。”<b>#2.历史说“逢低买入”</b></blockquote></p><p> I have&nbsp;repeatedly reminded readers&nbsp;that Apple stock is a better buy after a pullback. The chart below shows that, the larger the drawdown, the higher forward one-year returns tend to be. While the current 10% pullback is not quite a large one by historical standards, it is about as much as Apple stock has corrected since March 2021.</p><p><blockquote>我一再提醒读者，苹果股票在回调后更值得买入。下图显示，回撤越大，远期一年回报率往往越高。虽然按照历史标准，目前10%的回调幅度并不大，但与苹果股票自2021年3月以来的回调幅度大致相同。</blockquote></p><p> The buy-the-dip idea is&nbsp;shared&nbsp;by venture capitalist Jim Breyer. He has recently said that “for the last two years, when the mega-cap tech stocks have sold off significantly, I'm a buyer”. He believes that Big Tech, Apple included, are the best companies in the world. Therefore, why not buy equity in them when their shares go on sale?</p><p><blockquote>风险投资家吉姆·布雷耶（Jim Breyer）也有这种逢低买入的想法。他最近表示，“过去两年，当大型科技股大幅抛售时，我是买家”。他认为，包括苹果在内的大型科技公司是世界上最好的公司。因此，为什么不在他们的股票出售时购买他们的股权呢？</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9ce05b10f126efc9201e0ee1141711c6\" tg-width=\"684\" tg-height=\"408\" width=\"100%\" height=\"auto\"><span>Figure 3: Average one-year return on AAPL, by strategy.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图3：按策略划分的AAPL平均一年回报率。</span></p></blockquote></p><p> <b>#3. Seasonality improves in October</b></p><p><blockquote><b>#3.10月季节性改善</b></blockquote></p><p> Maybe surprising to those who subscribe to the efficient market theory, Apple share price tends to follow a seasonal pattern. Since the launch of the original iPhone in 2007, the stock performs well early in the summer, but sells off in September. This is probably the case because investors “buy the rumors” ahead of the late September iPhone launch, and “sell the news” in the last week of Q3.</p><p><blockquote>也许令那些认同有效市场理论的人感到惊讶的是，苹果股价往往遵循季节性模式。自2007年第一代iPhone推出以来，该股在初夏表现良好，但在9月份遭到抛售。这可能是因为投资者在9月下旬iPhone发布之前“买入谣言”，并在第三季度的最后一周“卖出消息”。</blockquote></p><p> The better news is that October tends to be a rebound month. The chart below shows that the historical returns for October, since 2007, has been nearly 4%. This number represents a compelling annualized gain of 56% that is much better than Apple’s own monthly average, let alone the S&amp;P 500’s.</p><p><blockquote>更好的消息是，10月往往是反弹月份。下图显示，自2007年以来，10月份的历史回报率接近4%。这个数字代表了引人注目的56%的年化涨幅，远好于苹果自己的月平均水平，更不用说标普500了。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6010d23d62d67b502ecf464bcd4b535d\" tg-width=\"718\" tg-height=\"428\" width=\"100%\" height=\"auto\"><span>Figure 4: AAPL average monthly returns since 2007.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图4：AAPL自2007年以来的平均月回报率。</span></p></blockquote></p><p> To be fair, seasonality deteriorates during the holiday season (sell-the-news-pressures again?), only to recover viciously in the first few months of the new year. Still, those looking for some short-term gains might be encouraged by how well AAPL tends to perform at the start of Q4.</p><p><blockquote>公平地说，季节性在节日期间恶化（又是抛售新闻的压力？），只是在新年的头几个月恶性复苏。尽管如此，那些寻求短期收益的人可能会对苹果公司在第四季度初的表现感到鼓舞。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: 3 Reasons Why The Selloff Is An Opportunity<blockquote>苹果股票：抛售是机会的3个原因</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: 3 Reasons Why The Selloff Is An Opportunity<blockquote>苹果股票：抛售是机会的3个原因</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-10-07 08:35</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Apple stock continues to hover around $140 apiece, the same levels of three months ago. The Apple Maven presents three reasons why shares may climb from here in the foreseeable future.</p><p><blockquote>苹果股价继续徘徊在每股140美元左右，与三个月前的水平相同。这位苹果专家提出了在可预见的未来股价可能会从这里攀升的三个原因。</blockquote></p><p> As Apple stock&nbsp;dips to just north of $140 apiece, many may feel uneasy holding shares when momentum is so unfavorable. But there are at least three reasons, all supported by investment experts and the Apple Maven, that suggest that buying AAPL now may be the right move.</p><p><blockquote>随着苹果股价跌至每股140美元以上，在势头如此不利的情况下，许多人可能会对持有股票感到不安。但至少有三个原因，都得到了投资专家和苹果专家的支持，表明现在收购苹果公司可能是正确的举动。</blockquote></p><p> Today, the Apple Maven looks at what I consider to be the three key pillars of the short-term bullish case on the Cupertino-based company’s stock.</p><p><blockquote>今天，这位苹果专家探讨了我认为短期看涨这家总部位于库比蒂诺的公司股票的三个关键支柱。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6a988efddcce991fe9a4da989de37cf2\" tg-width=\"1240\" tg-height=\"827\" width=\"100%\" height=\"auto\"><span>Figure 1: Apple logo.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：苹果标志。</span></p></blockquote></p><p> <b>#1. Selloff is not about Apple</b></p><p><blockquote><b>#1.抛售与苹果无关</b></blockquote></p><p> Few will argue that Apple’s quick 10% drop from the September 7 all-time high had anything to do with the company’s fundamentals. In fact,as I have recently presented, the core of Apple’s business has been in great shape: the iPhone 13 is proving to be a bigger deal than many previously expected.</p><p><blockquote>很少有人会认为苹果从9月7日的历史高点快速下跌10%与该公司的基本面有关。事实上，正如我最近介绍的那样，苹果业务的核心状况非常好：事实证明，iPhone 13比许多人之前预期的要大。</blockquote></p><p> Evidence that Apple’s performance is very likely unrelated to the recent share price decline can also be found in analysts’ expectations. Over the past 90 days, while AAPL price stayed flat at around $140 per share, 2021 EPS projections climbed more than 40 cents. Apply a conservative earnings multiple of 25 times to this delta, and we are looking at over $10 in per-share value that never materialized.</p><p><blockquote>苹果的业绩很可能与近期股价下跌无关的证据也可以在分析师的预期中找到。过去90天，虽然AAPL价格持平于每股140美元左右，但2021年每股收益预测却攀升了40多美分。将25倍的保守市盈率应用于该delta，我们看到的每股价值超过10美元，但从未实现。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f06a897cf92907ec889996f34932ed22\" tg-width=\"878\" tg-height=\"223\" width=\"100%\" height=\"auto\"><span>Figure 2: AAPL EPS trend.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：AAPL每股收益趋势。</span></p></blockquote></p><p> If the recent pullback in AAPL happened despite deterioration in fundamentals, then I find it reasonable to expect Apple stock to rebound in the foreseeable future. This also seems to be the opinion of Wedbush’s Dan Ives, who recently&nbsp;said&nbsp;the following:</p><p><blockquote>如果苹果公司最近的回调是在基本面恶化的情况下发生的，那么我认为有理由预期苹果股票在可预见的未来反弹。这似乎也是Wedbush的Dan Ives的观点，他最近发表了以下言论：</blockquote></p><p>   “We continue to believe this pressure on the tech sector is short-lived with our belief that tech stocks will be up 10%+ into year-end. The tech growth stories are being massively underestimated by the Street in our opinion, with 3Q earnings a major positive catalyst for the tech sector looking ahead.”  <b>#2. History says “buy dips”</b></p><p><blockquote>“我们仍然认为科技股面临的压力是短暂的，我们相信科技股到年底将上涨10%以上。我们认为，华尔街严重低估了科技股的增长故事，第三季度盈利是科技行业未来的主要积极催化剂。”<b>#2.历史说“逢低买入”</b></blockquote></p><p> I have&nbsp;repeatedly reminded readers&nbsp;that Apple stock is a better buy after a pullback. The chart below shows that, the larger the drawdown, the higher forward one-year returns tend to be. While the current 10% pullback is not quite a large one by historical standards, it is about as much as Apple stock has corrected since March 2021.</p><p><blockquote>我一再提醒读者，苹果股票在回调后更值得买入。下图显示，回撤越大，远期一年回报率往往越高。虽然按照历史标准，目前10%的回调幅度并不大，但与苹果股票自2021年3月以来的回调幅度大致相同。</blockquote></p><p> The buy-the-dip idea is&nbsp;shared&nbsp;by venture capitalist Jim Breyer. He has recently said that “for the last two years, when the mega-cap tech stocks have sold off significantly, I'm a buyer”. He believes that Big Tech, Apple included, are the best companies in the world. Therefore, why not buy equity in them when their shares go on sale?</p><p><blockquote>风险投资家吉姆·布雷耶（Jim Breyer）也有这种逢低买入的想法。他最近表示，“过去两年，当大型科技股大幅抛售时，我是买家”。他认为，包括苹果在内的大型科技公司是世界上最好的公司。因此，为什么不在他们的股票出售时购买他们的股权呢？</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9ce05b10f126efc9201e0ee1141711c6\" tg-width=\"684\" tg-height=\"408\" width=\"100%\" height=\"auto\"><span>Figure 3: Average one-year return on AAPL, by strategy.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图3：按策略划分的AAPL平均一年回报率。</span></p></blockquote></p><p> <b>#3. Seasonality improves in October</b></p><p><blockquote><b>#3.10月季节性改善</b></blockquote></p><p> Maybe surprising to those who subscribe to the efficient market theory, Apple share price tends to follow a seasonal pattern. Since the launch of the original iPhone in 2007, the stock performs well early in the summer, but sells off in September. This is probably the case because investors “buy the rumors” ahead of the late September iPhone launch, and “sell the news” in the last week of Q3.</p><p><blockquote>也许令那些认同有效市场理论的人感到惊讶的是，苹果股价往往遵循季节性模式。自2007年第一代iPhone推出以来，该股在初夏表现良好，但在9月份遭到抛售。这可能是因为投资者在9月下旬iPhone发布之前“买入谣言”，并在第三季度的最后一周“卖出消息”。</blockquote></p><p> The better news is that October tends to be a rebound month. The chart below shows that the historical returns for October, since 2007, has been nearly 4%. This number represents a compelling annualized gain of 56% that is much better than Apple’s own monthly average, let alone the S&amp;P 500’s.</p><p><blockquote>更好的消息是，10月往往是反弹月份。下图显示，自2007年以来，10月份的历史回报率接近4%。这个数字代表了引人注目的56%的年化涨幅，远好于苹果自己的月平均水平，更不用说标普500了。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6010d23d62d67b502ecf464bcd4b535d\" tg-width=\"718\" tg-height=\"428\" width=\"100%\" height=\"auto\"><span>Figure 4: AAPL average monthly returns since 2007.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图4：AAPL自2007年以来的平均月回报率。</span></p></blockquote></p><p> To be fair, seasonality deteriorates during the holiday season (sell-the-news-pressures again?), only to recover viciously in the first few months of the new year. Still, those looking for some short-term gains might be encouraged by how well AAPL tends to perform at the start of Q4.</p><p><blockquote>公平地说，季节性在节日期间恶化（又是抛售新闻的压力？），只是在新年的头几个月恶性复苏。尽管如此，那些寻求短期收益的人可能会对苹果公司在第四季度初的表现感到鼓舞。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/apple/stock/apple-stock-3-reasons-why-the-selloff-is-an-opportunity\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/apple-stock-3-reasons-why-the-selloff-is-an-opportunity","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165951132","content_text":"Apple stock continues to hover around $140 apiece, the same levels of three months ago. The Apple Maven presents three reasons why shares may climb from here in the foreseeable future.\nAs Apple stock dips to just north of $140 apiece, many may feel uneasy holding shares when momentum is so unfavorable. But there are at least three reasons, all supported by investment experts and the Apple Maven, that suggest that buying AAPL now may be the right move.\nToday, the Apple Maven looks at what I consider to be the three key pillars of the short-term bullish case on the Cupertino-based company’s stock.\nFigure 1: Apple logo.\n#1. Selloff is not about Apple\nFew will argue that Apple’s quick 10% drop from the September 7 all-time high had anything to do with the company’s fundamentals. In fact,as I have recently presented, the core of Apple’s business has been in great shape: the iPhone 13 is proving to be a bigger deal than many previously expected.\nEvidence that Apple’s performance is very likely unrelated to the recent share price decline can also be found in analysts’ expectations. Over the past 90 days, while AAPL price stayed flat at around $140 per share, 2021 EPS projections climbed more than 40 cents. Apply a conservative earnings multiple of 25 times to this delta, and we are looking at over $10 in per-share value that never materialized.\nFigure 2: AAPL EPS trend.\nIf the recent pullback in AAPL happened despite deterioration in fundamentals, then I find it reasonable to expect Apple stock to rebound in the foreseeable future. This also seems to be the opinion of Wedbush’s Dan Ives, who recently said the following:\n\n “We continue to believe this pressure on the tech sector is short-lived with our belief that tech stocks will be up 10%+ into year-end. The tech growth stories are being massively underestimated by the Street in our opinion, with 3Q earnings a major positive catalyst for the tech sector looking ahead.”\n\n#2. History says “buy dips”\nI have repeatedly reminded readers that Apple stock is a better buy after a pullback. The chart below shows that, the larger the drawdown, the higher forward one-year returns tend to be. While the current 10% pullback is not quite a large one by historical standards, it is about as much as Apple stock has corrected since March 2021.\nThe buy-the-dip idea is shared by venture capitalist Jim Breyer. He has recently said that “for the last two years, when the mega-cap tech stocks have sold off significantly, I'm a buyer”. He believes that Big Tech, Apple included, are the best companies in the world. Therefore, why not buy equity in them when their shares go on sale?\nFigure 3: Average one-year return on AAPL, by strategy.\n#3. Seasonality improves in October\nMaybe surprising to those who subscribe to the efficient market theory, Apple share price tends to follow a seasonal pattern. Since the launch of the original iPhone in 2007, the stock performs well early in the summer, but sells off in September. This is probably the case because investors “buy the rumors” ahead of the late September iPhone launch, and “sell the news” in the last week of Q3.\nThe better news is that October tends to be a rebound month. The chart below shows that the historical returns for October, since 2007, has been nearly 4%. This number represents a compelling annualized gain of 56% that is much better than Apple’s own monthly average, let alone the S&P 500’s.\nFigure 4: AAPL average monthly returns since 2007.\nTo be fair, seasonality deteriorates during the holiday season (sell-the-news-pressures again?), only to recover viciously in the first few months of the new year. Still, those looking for some short-term gains might be encouraged by how well AAPL tends to perform at the start of Q4.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":972,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820221968,"gmtCreate":1633396594976,"gmtModify":1633396595095,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INO\">$Inovio Pharmaceuticals(INO)$</a>Buying point $6.25Target $ 7.20","listText":"<a href=\"https://laohu8.com/S/INO\">$Inovio Pharmaceuticals(INO)$</a>Buying point $6.25Target $ 7.20","text":"$Inovio Pharmaceuticals(INO)$Buying point $6.25Target $ 7.20","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820221968","isVote":1,"tweetType":1,"viewCount":481,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820229269,"gmtCreate":1633396453929,"gmtModify":1633396454060,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Exela tech (xela ) $$$Entry point&nbsp; $1.58&nbsp;Target $2.05Buy at dip&nbsp;","listText":"Exela tech (xela ) $$$Entry point&nbsp; $1.58&nbsp;Target $2.05Buy at dip&nbsp;","text":"Exela tech (xela ) $$$Entry point $1.58 Target $2.05Buy at dip","images":[{"img":"https://static.tigerbbs.com/1805a8f0a1a0d3df53d0a1c66d08d104","width":"1080","height":"2220"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820229269","isVote":1,"tweetType":1,"viewCount":715,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":864567773,"gmtCreate":1633133203349,"gmtModify":1633133203481,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Buying point below $8&nbsp;","listText":"Buying point below $8&nbsp;","text":"Buying point below $8","images":[{"img":"https://static.tigerbbs.com/35452eac26936c3f4ab316d23b7ab467","width":"1080","height":"2220"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864567773","isVote":1,"tweetType":1,"viewCount":612,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":868721471,"gmtCreate":1632706667893,"gmtModify":1632798426390,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Top glove buy in zone 0.85&nbsp;Will pump up to 1.00<a href=\"https://laohu8.com/S/BVA.SI\">$TOP GLOVE CORPORATION BHD(BVA.SI)$</a>","listText":"Top glove buy in zone 0.85&nbsp;Will pump up to 1.00<a href=\"https://laohu8.com/S/BVA.SI\">$TOP GLOVE CORPORATION BHD(BVA.SI)$</a>","text":"Top glove buy in zone 0.85 Will pump up to 1.00$TOP GLOVE CORPORATION BHD(BVA.SI)$","images":[{"img":"https://static.tigerbbs.com/0e37465dd42407d6684b229cbbb3345f","width":"1080","height":"2220"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/868721471","isVote":1,"tweetType":1,"viewCount":872,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":868302700,"gmtCreate":1632585716400,"gmtModify":1632654722451,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"title":"wish best entry point","htmlText":"Buy at below $6.00 good opportunity and better investment for long term","listText":"Buy at below $6.00 good opportunity and better investment for long term","text":"Buy at below $6.00 good opportunity and better investment for long term","images":[{"img":"https://static.tigerbbs.com/614a5fe435116c3332dd35f50e5cd125","width":"1080","height":"2220"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/868302700","isVote":1,"tweetType":1,"viewCount":985,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":861828201,"gmtCreate":1632484913303,"gmtModify":1632718936364,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Meli looks good for long-term investment.&nbsp; Buy at dip","listText":"Meli looks good for long-term investment.&nbsp; Buy at dip","text":"Meli looks good for long-term investment. Buy at dip","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/861828201","repostId":"2169469055","repostType":4,"isVote":1,"tweetType":1,"viewCount":844,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861821530,"gmtCreate":1632484779120,"gmtModify":1632718954370,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Hahaha . What a big joke. Pass over 100k may be posible","listText":"Hahaha . What a big joke. Pass over 100k may be posible","text":"Hahaha . What a big joke. Pass over 100k may be posible","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/861821530","repostId":"1199759162","repostType":4,"isVote":1,"tweetType":1,"viewCount":580,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861829489,"gmtCreate":1632484517941,"gmtModify":1632718996387,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Wish share can be trade below $6 . Its good opportunity to add on when share price go down below $ 6 [财迷] [财迷]&nbsp;","listText":"Wish share can be trade below $6 . Its good opportunity to add on when share price go down below $ 6 [财迷] [财迷]&nbsp;","text":"Wish share can be trade below $6 . Its good opportunity to add on when share price go down below $ 6 [财迷] [财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/861829489","isVote":1,"tweetType":1,"viewCount":614,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":860671889,"gmtCreate":1632179862741,"gmtModify":1632802343466,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Can invest more when the share price drop below&nbsp; 40","listText":"Can invest more when the share price drop below&nbsp; 40","text":"Can invest more when the share price drop below 40","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/860671889","isVote":1,"tweetType":1,"viewCount":404,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":823046429,"gmtCreate":1633567652267,"gmtModify":1633567652395,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Like please&nbsp;","listText":"Like please&nbsp;","text":"Like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/823046429","repostId":"2173948202","repostType":4,"isVote":1,"tweetType":1,"viewCount":2600,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603328778,"gmtCreate":1638368688641,"gmtModify":1638368688845,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Pfizer","listText":"Pfizer","text":"Pfizer","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/603328778","repostId":"1119742422","repostType":4,"repost":{"id":"1119742422","kind":"news","pubTimestamp":1638368504,"share":"https://www.laohu8.com/m/news/1119742422?lang=zh_CN&edition=full","pubTime":"2021-12-01 22:21","market":"us","language":"en","title":"Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna或辉瑞股票：随着奥密克戎蔓延，该买哪一只？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1119742422","media":"TheStreet","summary":"Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks ","content":"<p>Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.</p><p><blockquote>自发现奥密克戎变种以来，对大流行的担忧再次出现，疫苗相关股票重新成为人们关注的焦点。今天，我们仔细看看Moderna和辉瑞的股票。</blockquote></p><p> COVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.</p><p><blockquote>新冠肺炎继续困扰市场。新变种奥密克戎重新引发了全世界对新的健康和经济危机的担忧，因为人们对这种变种如何影响接种疫苗和未接种疫苗的人知之甚少。</blockquote></p><p> The stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&amp;P 500&nbsp;dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock&nbsp;was up a more modest 2.5%.</p><p><blockquote>11月26日星期五，奥密克戎新闻频道播出后，股市遭到抛售。由于不确定性，标普500下跌2%。Moderna股票是为数不多的上涨者之一，该股在周五交易时段上涨了20%，而辉瑞股票则小幅上涨了2.5%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b55d87c377ec124bb84173bfb955b9fa\" tg-width=\"689\" tg-height=\"621\" width=\"100%\" height=\"auto\"><span>Figure 1: SPY, MRNA and PFE performance in the past 5-trading days.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：过去5个交易日的SPDR标普500指数ETF、MRNA和PFE表现。</span></p></blockquote></p><p> Between two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?</p><p><blockquote>在两家主要的COVID-19疫苗制造商之间，我们评估了Moderna和辉瑞的股票，并问自己：在奥密克戎恐惧挥之不去的情况下，哪一家更值得买入？</blockquote></p><p> <b>Wall Street is neutral on Moderna</b></p><p><blockquote><b>华尔街对Moderna持中立态度</b></blockquote></p><p> Moderna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.</p><p><blockquote>Moderna股票目前有13名分析师一致持有，平均目标价为298美元，这表明较当前水平下跌17%。华尔街的评估表明，股价可能已经领先于基本面，因为自COVID-19大流行开始以来，MRNA已上涨超过1,200%。</blockquote></p><p> The most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who&nbsp;reiterated&nbsp;his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.</p><p><blockquote>关于Moderna股票的最新报告来自Piper Sandler的Edward Tenthoff，他重申了买入建议，并在奥密克戎新闻的支持下预测目标价为348美元。分析师认为，该公司已为新变种的出现做好了准备，并且“非常适合快速更换新版本的刺突抗原”以制造新的COVID-19疫苗。</blockquote></p><p> Morgan Stanley’s Matthew Harrison&nbsp;reiterated&nbsp;his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.</p><p><blockquote>摩根士丹利的Matthew Harrison一周前重申了对MRNA的中性评级，目标价为313美元。该分析师提到，Moderna年底前流感疫苗数据的公布可能会成为该股的积极催化剂。如果结果是积极的，市场可能会预计长期流感和新冠疫苗收入约为100亿美元，使股价上涨10%。</blockquote></p><p> <b>Pfizer: moderate buy, but experts are skeptical</b></p><p><blockquote><b>辉瑞：适度买入，但专家持怀疑态度</b></blockquote></p><p> Wall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.</p><p><blockquote>根据股票评级，华尔街目前看好辉瑞。然而，平均价格目标共识表明，继11月上涨之后，估值可能会被拉低。根据13份报告，PFE给予适度买入建议，平均目标价为50美元。</blockquote></p><p> JPMorgan‘s Chris Schott&nbsp;raised&nbsp;the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.</p><p><blockquote>摩根大通的Chris Schott将辉瑞的目标价从42美元上调至53美元，并维持中性评级。Covid仍然是辉瑞故事的焦点，Comirnaty和Paxlovid的销售额“将明显超出预期”。虽然分析师认为该公司核心业务的上涨空间有限，但他不会对近期股价上涨感到惊讶奥密克戎头条新闻。</blockquote></p><p> The most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is&nbsp;skeptical&nbsp;on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.</p><p><blockquote>PFE的最新更新来自瑞穗证券的Vamil Divan。他对辉瑞股票持怀疑态度，并认为下行风险为16%。但这位分析师表示，奥密克戎可能会增加近期对辉瑞COVID-19疫苗的需求，尤其是加强剂量。</blockquote></p><p> <b>Wall Street Memes’ take</b></p><p><blockquote><b>华尔街模因的看法</b></blockquote></p><p> COVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.</p><p><blockquote>COVID-19疫苗制造商在短期内自然可能会从奥密克戎担忧中受益。例如，自2020年3月COVID-19大流行开始以来，Moderna的股价已上涨超过1,200%，而辉瑞股价同期上涨了79%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/198c43532bf2d097bc94e078b539a044\" tg-width=\"684\" tg-height=\"577\" width=\"100%\" height=\"auto\"><span>Figure 2: MRNA and PFE performance in the past 5-years.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：过去5年的MRNA和PFE表现。</span></p></blockquote></p><p> Pfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.</p><p><blockquote>辉瑞比Moderna大得多，市值为3000亿美元，而Moderna为1330亿美元。两家公司都拥有强大的疫苗管道和技术，但Moderna可能会从当前的大流行中受益，因为它更像是一只纯粹的股票。</blockquote></p><p> Due to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.</p><p><blockquote>由于商业模式多元化，我们认为MRNA是COVID-19发展的更好短期赌注。然而，出于同样的原因，并且由于2023年市盈率高达32倍，该股可能会更加波动，并存在更高的下行风险。另一方面，PFE可能是整个医疗保健领域更好的长期押注，特别是考虑到2023年去风险市盈率仅为13倍。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna或辉瑞股票：随着奥密克戎蔓延，该买哪一只？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna或辉瑞股票：随着奥密克戎蔓延，该买哪一只？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-12-01 22:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.</p><p><blockquote>自发现奥密克戎变种以来，对大流行的担忧再次出现，疫苗相关股票重新成为人们关注的焦点。今天，我们仔细看看Moderna和辉瑞的股票。</blockquote></p><p> COVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.</p><p><blockquote>新冠肺炎继续困扰市场。新变种奥密克戎重新引发了全世界对新的健康和经济危机的担忧，因为人们对这种变种如何影响接种疫苗和未接种疫苗的人知之甚少。</blockquote></p><p> The stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&amp;P 500&nbsp;dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock&nbsp;was up a more modest 2.5%.</p><p><blockquote>11月26日星期五，奥密克戎新闻频道播出后，股市遭到抛售。由于不确定性，标普500下跌2%。Moderna股票是为数不多的上涨者之一，该股在周五交易时段上涨了20%，而辉瑞股票则小幅上涨了2.5%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b55d87c377ec124bb84173bfb955b9fa\" tg-width=\"689\" tg-height=\"621\" width=\"100%\" height=\"auto\"><span>Figure 1: SPY, MRNA and PFE performance in the past 5-trading days.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：过去5个交易日的SPDR标普500指数ETF、MRNA和PFE表现。</span></p></blockquote></p><p> Between two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?</p><p><blockquote>在两家主要的COVID-19疫苗制造商之间，我们评估了Moderna和辉瑞的股票，并问自己：在奥密克戎恐惧挥之不去的情况下，哪一家更值得买入？</blockquote></p><p> <b>Wall Street is neutral on Moderna</b></p><p><blockquote><b>华尔街对Moderna持中立态度</b></blockquote></p><p> Moderna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.</p><p><blockquote>Moderna股票目前有13名分析师一致持有，平均目标价为298美元，这表明较当前水平下跌17%。华尔街的评估表明，股价可能已经领先于基本面，因为自COVID-19大流行开始以来，MRNA已上涨超过1,200%。</blockquote></p><p> The most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who&nbsp;reiterated&nbsp;his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.</p><p><blockquote>关于Moderna股票的最新报告来自Piper Sandler的Edward Tenthoff，他重申了买入建议，并在奥密克戎新闻的支持下预测目标价为348美元。分析师认为，该公司已为新变种的出现做好了准备，并且“非常适合快速更换新版本的刺突抗原”以制造新的COVID-19疫苗。</blockquote></p><p> Morgan Stanley’s Matthew Harrison&nbsp;reiterated&nbsp;his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.</p><p><blockquote>摩根士丹利的Matthew Harrison一周前重申了对MRNA的中性评级，目标价为313美元。该分析师提到，Moderna年底前流感疫苗数据的公布可能会成为该股的积极催化剂。如果结果是积极的，市场可能会预计长期流感和新冠疫苗收入约为100亿美元，使股价上涨10%。</blockquote></p><p> <b>Pfizer: moderate buy, but experts are skeptical</b></p><p><blockquote><b>辉瑞：适度买入，但专家持怀疑态度</b></blockquote></p><p> Wall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.</p><p><blockquote>根据股票评级，华尔街目前看好辉瑞。然而，平均价格目标共识表明，继11月上涨之后，估值可能会被拉低。根据13份报告，PFE给予适度买入建议，平均目标价为50美元。</blockquote></p><p> JPMorgan‘s Chris Schott&nbsp;raised&nbsp;the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.</p><p><blockquote>摩根大通的Chris Schott将辉瑞的目标价从42美元上调至53美元，并维持中性评级。Covid仍然是辉瑞故事的焦点，Comirnaty和Paxlovid的销售额“将明显超出预期”。虽然分析师认为该公司核心业务的上涨空间有限，但他不会对近期股价上涨感到惊讶奥密克戎头条新闻。</blockquote></p><p> The most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is&nbsp;skeptical&nbsp;on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.</p><p><blockquote>PFE的最新更新来自瑞穗证券的Vamil Divan。他对辉瑞股票持怀疑态度，并认为下行风险为16%。但这位分析师表示，奥密克戎可能会增加近期对辉瑞COVID-19疫苗的需求，尤其是加强剂量。</blockquote></p><p> <b>Wall Street Memes’ take</b></p><p><blockquote><b>华尔街模因的看法</b></blockquote></p><p> COVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.</p><p><blockquote>COVID-19疫苗制造商在短期内自然可能会从奥密克戎担忧中受益。例如，自2020年3月COVID-19大流行开始以来，Moderna的股价已上涨超过1,200%，而辉瑞股价同期上涨了79%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/198c43532bf2d097bc94e078b539a044\" tg-width=\"684\" tg-height=\"577\" width=\"100%\" height=\"auto\"><span>Figure 2: MRNA and PFE performance in the past 5-years.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：过去5年的MRNA和PFE表现。</span></p></blockquote></p><p> Pfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.</p><p><blockquote>辉瑞比Moderna大得多，市值为3000亿美元，而Moderna为1330亿美元。两家公司都拥有强大的疫苗管道和技术，但Moderna可能会从当前的大流行中受益，因为它更像是一只纯粹的股票。</blockquote></p><p> Due to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.</p><p><blockquote>由于商业模式多元化，我们认为MRNA是COVID-19发展的更好短期赌注。然而，出于同样的原因，并且由于2023年市盈率高达32倍，该股可能会更加波动，并存在更高的下行风险。另一方面，PFE可能是整个医疗保健领域更好的长期押注，特别是考虑到2023年去风险市盈率仅为13倍。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119742422","content_text":"Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.\nCOVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.\nThe stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&P 500 dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock was up a more modest 2.5%.\nFigure 1: SPY, MRNA and PFE performance in the past 5-trading days.\nBetween two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?\nWall Street is neutral on Moderna\nModerna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.\nThe most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who reiterated his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.\nMorgan Stanley’s Matthew Harrison reiterated his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.\nPfizer: moderate buy, but experts are skeptical\nWall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.\nJPMorgan‘s Chris Schott raised the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.\nThe most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is skeptical on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.\nWall Street Memes’ take\nCOVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.\nFigure 2: MRNA and PFE performance in the past 5-years.\nPfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.\nDue to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.","news_type":1,"symbols_score_info":{"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2012,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877648212,"gmtCreate":1637929743063,"gmtModify":1637929743124,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Its good","listText":"Its good","text":"Its good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877648212","repostId":"1145084508","repostType":4,"repost":{"id":"1145084508","kind":"news","pubTimestamp":1637929067,"share":"https://www.laohu8.com/m/news/1145084508?lang=zh_CN&edition=full","pubTime":"2021-11-26 20:17","market":"us","language":"en","title":"Fear, Not Calculated Trading, Is Behind Today’s Covid Market Crash<blockquote>今天新冠市场崩盘的背后是恐惧，而不是经过计算的交易</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1145084508","media":"Barrons","summary":"Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at ","content":"<p>Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at the stock market today will shatter that illusion.</p><p><blockquote>感恩节聚会可能会让许多人觉得疫情已经结束。看看今天的股市，这种幻想就会破灭。</blockquote></p><p> Concerns around a new, heavily-mutated variant of Covid-19 identified in South Africa have rocked investor confidence. Stocks are plunging around the world, oil prices are dropping, bond yields are sliding—even Bitcoin is feeling the heat. There is a broad reversion to frenzied, theme-based trading. Vaccine stocks and pandemic plays like Zoom are surging while airline stocks are falling.</p><p><blockquote>对南非发现的一种新的、严重突变的Covid-19变种的担忧动摇了投资者的信心。全球股市暴跌，油价下跌，债券收益率下滑——就连比特币也感受到了压力。疯狂的、基于主题的交易普遍回归。疫苗股和Zoom等流行病股正在飙升，而航空股却在下跌。</blockquote></p><p> What we are seeing is fear and uncertainty. Sell first, ask questions later. And low trading volumes globally due to the Thanksgiving holiday is likely exacerbating volatility.</p><p><blockquote>我们看到的是恐惧和不确定性。先卖，后问问题。感恩节假期导致的全球交易量低迷可能会加剧波动。</blockquote></p><p> What we are not seeing is markets intelligently pricing in the impact of this new development. Scientific experts have yet to draw conclusions about the mutation, known for now as B.1.1.529, and there are less than 100 confirmed cases.</p><p><blockquote>我们没有看到市场对这一新发展的影响进行明智的定价。科学专家尚未对目前被称为B.1.1.529的突变得出结论，确诊病例不到100例。</blockquote></p><p> That’s not to say fear is misplaced. Early indications are that B.1.1.529 is significantly different from other variants, and, truly, the worst case scenario is that it’s more deadly, contagious, and vaccine-resistant than what we’ve already faced.</p><p><blockquote>这并不是说恐惧是错误的。早期迹象表明，B.1.1.529与其他变种有很大不同，事实上，最糟糕的情况是它比我们已经面临的更具致命性、传染性和疫苗耐药性。</blockquote></p><p> But we don’t know that yet. Similar market shockwaves caused by the Delta variant over the summer eventually subsided. Though it led to a surge in cases around the world, modern science was able to tackle it and move on. Hopefully the same can be said of this variant.</p><p><blockquote>但我们还不知道。夏季德尔塔变异毒株引发的类似市场冲击波最终平息。尽管它导致了世界各地病例的激增，但现代科学能够解决它并继续前进。希望这种变体也是如此。</blockquote></p><p> But for now investors will have to put up with heightened uncertainty—the markets’ worst enemy.</p><p><blockquote>但目前投资者将不得不忍受不确定性的加剧——这是市场最大的敌人。</blockquote></p><p></p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fear, Not Calculated Trading, Is Behind Today’s Covid Market Crash<blockquote>今天新冠市场崩盘的背后是恐惧，而不是经过计算的交易</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFear, Not Calculated Trading, Is Behind Today’s Covid Market Crash<blockquote>今天新冠市场崩盘的背后是恐惧，而不是经过计算的交易</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-11-26 20:17</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at the stock market today will shatter that illusion.</p><p><blockquote>感恩节聚会可能会让许多人觉得疫情已经结束。看看今天的股市，这种幻想就会破灭。</blockquote></p><p> Concerns around a new, heavily-mutated variant of Covid-19 identified in South Africa have rocked investor confidence. Stocks are plunging around the world, oil prices are dropping, bond yields are sliding—even Bitcoin is feeling the heat. There is a broad reversion to frenzied, theme-based trading. Vaccine stocks and pandemic plays like Zoom are surging while airline stocks are falling.</p><p><blockquote>对南非发现的一种新的、严重突变的Covid-19变种的担忧动摇了投资者的信心。全球股市暴跌，油价下跌，债券收益率下滑——就连比特币也感受到了压力。疯狂的、基于主题的交易普遍回归。疫苗股和Zoom等流行病股正在飙升，而航空股却在下跌。</blockquote></p><p> What we are seeing is fear and uncertainty. Sell first, ask questions later. And low trading volumes globally due to the Thanksgiving holiday is likely exacerbating volatility.</p><p><blockquote>我们看到的是恐惧和不确定性。先卖，后问问题。感恩节假期导致的全球交易量低迷可能会加剧波动。</blockquote></p><p> What we are not seeing is markets intelligently pricing in the impact of this new development. Scientific experts have yet to draw conclusions about the mutation, known for now as B.1.1.529, and there are less than 100 confirmed cases.</p><p><blockquote>我们没有看到市场对这一新发展的影响进行明智的定价。科学专家尚未对目前被称为B.1.1.529的突变得出结论，确诊病例不到100例。</blockquote></p><p> That’s not to say fear is misplaced. Early indications are that B.1.1.529 is significantly different from other variants, and, truly, the worst case scenario is that it’s more deadly, contagious, and vaccine-resistant than what we’ve already faced.</p><p><blockquote>这并不是说恐惧是错误的。早期迹象表明，B.1.1.529与其他变种有很大不同，事实上，最糟糕的情况是它比我们已经面临的更具致命性、传染性和疫苗耐药性。</blockquote></p><p> But we don’t know that yet. Similar market shockwaves caused by the Delta variant over the summer eventually subsided. Though it led to a surge in cases around the world, modern science was able to tackle it and move on. Hopefully the same can be said of this variant.</p><p><blockquote>但我们还不知道。夏季德尔塔变异毒株引发的类似市场冲击波最终平息。尽管它导致了世界各地病例的激增，但现代科学能够解决它并继续前进。希望这种变体也是如此。</blockquote></p><p> But for now investors will have to put up with heightened uncertainty—the markets’ worst enemy.</p><p><blockquote>但目前投资者将不得不忍受不确定性的加剧——这是市场最大的敌人。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/articles/things-to-know-today-51637926639?mod=newsviewer_click\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.marketwatch.com/articles/things-to-know-today-51637926639?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1145084508","content_text":"Gathering over Thanksgiving may have lulled many into feeling that the pandemic is over. Looking at the stock market today will shatter that illusion.\nConcerns around a new, heavily-mutated variant of Covid-19 identified in South Africa have rocked investor confidence. Stocks are plunging around the world, oil prices are dropping, bond yields are sliding—even Bitcoin is feeling the heat. There is a broad reversion to frenzied, theme-based trading. Vaccine stocks and pandemic plays like Zoom are surging while airline stocks are falling.\nWhat we are seeing is fear and uncertainty. Sell first, ask questions later. And low trading volumes globally due to the Thanksgiving holiday is likely exacerbating volatility.\nWhat we are not seeing is markets intelligently pricing in the impact of this new development. Scientific experts have yet to draw conclusions about the mutation, known for now as B.1.1.529, and there are less than 100 confirmed cases.\nThat’s not to say fear is misplaced. Early indications are that B.1.1.529 is significantly different from other variants, and, truly, the worst case scenario is that it’s more deadly, contagious, and vaccine-resistant than what we’ve already faced.\nBut we don’t know that yet. Similar market shockwaves caused by the Delta variant over the summer eventually subsided. Though it led to a surge in cases around the world, modern science was able to tackle it and move on. Hopefully the same can be said of this variant.\nBut for now investors will have to put up with heightened uncertainty—the markets’ worst enemy.","news_type":1,"symbols_score_info":{".SPX":0.9,".DJI":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":1702,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847705383,"gmtCreate":1636552134922,"gmtModify":1636552135082,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847705383","repostId":"1112315702","repostType":4,"isVote":1,"tweetType":1,"viewCount":2229,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821988958,"gmtCreate":1633686357602,"gmtModify":1633686357720,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Its a good start","listText":"Its a good start","text":"Its a good start","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/821988958","repostId":"1108043623","repostType":4,"repost":{"id":"1108043623","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633682657,"share":"https://www.laohu8.com/m/news/1108043623?lang=zh_CN&edition=full","pubTime":"2021-10-08 16:44","market":"us","language":"en","title":"Vaxart gained 7% in premarket trading<blockquote>Vaxart在盘前交易中上涨7%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1108043623","media":"Tiger Newspress","summary":"(Oct 8) Vaxart, Inc shares are up 7% in premarket trading after publishing results in an animal mode","content":"<p>(Oct 8)&nbsp;<b><a href=\"https://laohu8.com/S/VXRT\">Vaxart, Inc</a></b> shares are&nbsp;up 7%&nbsp;in premarket trading after&nbsp;publishing results in an animal model that its COVID-19 vaccine pill can reduce airborne transmission of SARS-CoV-2.</p><p><blockquote>（10月8日）<b><a href=\"https://laohu8.com/S/VXRT\">Vaxart公司</a></b>在公布动物模型结果表明其COVID-19疫苗可以减少新型冠状病毒病毒的空气传播后，该公司股价在盘前交易中上涨7%。</blockquote></p><p> Hamsters were vaccinated orally or intranasally with the vaccine candidate and then exposed to high levels of the COVID-19 virus to promote vaccine breakthrough. Vaccinated hamsters cleared the virus in the nose and lungs quickly.</p><p><blockquote>仓鼠口服或鼻内接种候选疫苗，然后暴露于高水平的新冠肺炎病毒，以促进疫苗突破。接种疫苗的仓鼠很快清除了鼻子和肺部的病毒。</blockquote></p><p> But before clearing the infection, vaccinated hamsters were exposed to unvaccinated hamsters. The vaccinated hamsters infected fewer hamsters and created less severe clinical symptoms than did unvaccinated hamsters.</p><p><blockquote>但在清除感染之前，接种疫苗的仓鼠暴露于未接种疫苗的仓鼠。与未接种疫苗的仓鼠相比，接种疫苗的仓鼠感染的仓鼠更少，产生的临床症状也更轻。</blockquote></p><p> Results were published in&nbsp;BioRxiv, and have yet to be peer-reviewed.</p><p><blockquote>结果发表在BioRxiv上，尚未经过同行评审。</blockquote></p><p> Vaxart yesterday&nbsp;began recruitment in a phase 2 trial of the oral COVID vaccine.</p><p><blockquote>Vaxart昨天开始招募口服新冠疫苗的2期试验。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1ebf72c0d5d89ceb2daa800e4fd962dc\" tg-width=\"1176\" tg-height=\"569\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaxart gained 7% in premarket trading<blockquote>Vaxart在盘前交易中上涨7%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaxart gained 7% in premarket trading<blockquote>Vaxart在盘前交易中上涨7%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-10-08 16:44</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>(Oct 8)&nbsp;<b><a href=\"https://laohu8.com/S/VXRT\">Vaxart, Inc</a></b> shares are&nbsp;up 7%&nbsp;in premarket trading after&nbsp;publishing results in an animal model that its COVID-19 vaccine pill can reduce airborne transmission of SARS-CoV-2.</p><p><blockquote>（10月8日）<b><a href=\"https://laohu8.com/S/VXRT\">Vaxart公司</a></b>在公布动物模型结果表明其COVID-19疫苗可以减少新型冠状病毒病毒的空气传播后，该公司股价在盘前交易中上涨7%。</blockquote></p><p> Hamsters were vaccinated orally or intranasally with the vaccine candidate and then exposed to high levels of the COVID-19 virus to promote vaccine breakthrough. Vaccinated hamsters cleared the virus in the nose and lungs quickly.</p><p><blockquote>仓鼠口服或鼻内接种候选疫苗，然后暴露于高水平的新冠肺炎病毒，以促进疫苗突破。接种疫苗的仓鼠很快清除了鼻子和肺部的病毒。</blockquote></p><p> But before clearing the infection, vaccinated hamsters were exposed to unvaccinated hamsters. The vaccinated hamsters infected fewer hamsters and created less severe clinical symptoms than did unvaccinated hamsters.</p><p><blockquote>但在清除感染之前，接种疫苗的仓鼠暴露于未接种疫苗的仓鼠。与未接种疫苗的仓鼠相比，接种疫苗的仓鼠感染的仓鼠更少，产生的临床症状也更轻。</blockquote></p><p> Results were published in&nbsp;BioRxiv, and have yet to be peer-reviewed.</p><p><blockquote>结果发表在BioRxiv上，尚未经过同行评审。</blockquote></p><p> Vaxart yesterday&nbsp;began recruitment in a phase 2 trial of the oral COVID vaccine.</p><p><blockquote>Vaxart昨天开始招募口服新冠疫苗的2期试验。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1ebf72c0d5d89ceb2daa800e4fd962dc\" tg-width=\"1176\" tg-height=\"569\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VXRT":"Vaxart, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108043623","content_text":"(Oct 8) Vaxart, Inc shares are up 7% in premarket trading after publishing results in an animal model that its COVID-19 vaccine pill can reduce airborne transmission of SARS-CoV-2.\nHamsters were vaccinated orally or intranasally with the vaccine candidate and then exposed to high levels of the COVID-19 virus to promote vaccine breakthrough. Vaccinated hamsters cleared the virus in the nose and lungs quickly.\nBut before clearing the infection, vaccinated hamsters were exposed to unvaccinated hamsters. The vaccinated hamsters infected fewer hamsters and created less severe clinical symptoms than did unvaccinated hamsters.\nResults were published in BioRxiv, and have yet to be peer-reviewed.\nVaxart yesterday began recruitment in a phase 2 trial of the oral COVID vaccine.","news_type":1,"symbols_score_info":{"VXRT":0.9}},"isVote":1,"tweetType":1,"viewCount":1916,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693375908,"gmtCreate":1639978751240,"gmtModify":1639978751354,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Tesla can buy for long term","listText":"Tesla can buy for long term","text":"Tesla can buy for long term","images":[{"img":"https://static.tigerbbs.com/1b84366b2a5685aed92cad7ddb219434","width":"1080","height":"2220"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693375908","isVote":1,"tweetType":1,"viewCount":2696,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":868721471,"gmtCreate":1632706667893,"gmtModify":1632798426390,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Top glove buy in zone 0.85&nbsp;Will pump up to 1.00<a href=\"https://laohu8.com/S/BVA.SI\">$TOP GLOVE CORPORATION BHD(BVA.SI)$</a>","listText":"Top glove buy in zone 0.85&nbsp;Will pump up to 1.00<a href=\"https://laohu8.com/S/BVA.SI\">$TOP GLOVE CORPORATION BHD(BVA.SI)$</a>","text":"Top glove buy in zone 0.85 Will pump up to 1.00$TOP GLOVE CORPORATION BHD(BVA.SI)$","images":[{"img":"https://static.tigerbbs.com/0e37465dd42407d6684b229cbbb3345f","width":"1080","height":"2220"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/868721471","isVote":1,"tweetType":1,"viewCount":872,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":861828201,"gmtCreate":1632484913303,"gmtModify":1632718936364,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Meli looks good for long-term investment.&nbsp; Buy at dip","listText":"Meli looks good for long-term investment.&nbsp; Buy at dip","text":"Meli looks good for long-term investment. Buy at dip","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/861828201","repostId":"2169469055","repostType":4,"isVote":1,"tweetType":1,"viewCount":844,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856734075,"gmtCreate":1635212355063,"gmtModify":1635212355180,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856734075","repostId":"1184179575","repostType":2,"isVote":1,"tweetType":1,"viewCount":2407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":692973818,"gmtCreate":1640835449206,"gmtModify":1640835449366,"author":{"id":"3582495099582633","authorId":"3582495099582633","name":"fongms","avatar":"https://static.tigerbbs.com/af39086f575d7bf8ec2d34dcb560bb18","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582495099582633","idStr":"3582495099582633"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692973818","repostId":"1100360696","repostType":4,"isVote":1,"tweetType":1,"viewCount":2441,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}